Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to _____________

Commission File Number: 001-41532

HUDSON ACQUISITION I CORP.

(Exact Name of Registrant as Specified in Its Charter)

Delaware		86- 2712843
(State of Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

19 West 44th Street, Suite 1001, New York, NY		10036
(Address of Principal Executive Offices)		(ZIP Code)

(347) 410-4710

(Registrant’s Telephone Number, Including Area Code)

Indicate by check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act).

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	HUDA	The Nasdaq Stock Market LLC
Rights	HUDAR	The Nasdaq Stock Market LLC
Units	HUDAU	The Nasdaq Stock Market LLC

As of November 12, 2024, there were 2,181,088 shares of common stock, par value $0.0001 per share of the registrant issued and outstanding.

HUDSON ACQUISITION I CORP.

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024

TABLE OF CONTENTS

		Page

PART I. FINANCIAL INFORMATION		1

ITEM 1.	Financial Statements	1

	Condensed Balance Sheets (Unaudited)	1

	Condensed Statements of Operations (Unaudited)	2

	Condensed Statements of Changes in Stockholder’s Deficit (Unaudited)	3

	Condensed Statements of Cash Flows (Unaudited)	4

	Notes to Unaudited Condensed Financial Statements	5

ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19

ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk	24

ITEM 4.	Controls and Procedures	24

PART II. OTHER INFORMATION		25

ITEM 1.	Legal Proceedings	25

ITEM 1A.	Risk Factors	25

ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	25

ITEM 3.	Defaults Upon Senior Securities	25

ITEM 4.	Mine Safety Disclosures	25

ITEM 5.	Other Information	25

ITEM 6.	Exhibits	26

SIGNATURES		27

PART I - FINANCIAL INFORMATION

ITEM 1. Financial Statements

HUDSON ACQUISITION I CORP.

CONDENSED BALANCE SHEETS

(UNAUDITED)

	September 30, 2024			December 31, 2023
ASSETS
Current assets:
Cash	$	378,755		$	11,700
Prepaid expenses and other current assets		55,000			11,748
Total current assets		433,755			23,448

Marketable securities held in Trust Account		1,109,108			26,036,953
Interest receivable on cash and marketable securities held in the Trust Account		4,586			-
Total assets	$	1,547,449		$	26,060,401

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued liabilities	$	455,944		$	601,469
Advance from target company for de-SPAC transaction		1,477,765			-
Franchise tax payable		283,074			68,308
Income tax payable		941,000			764,000
Excise tax payable		719,176			461,700
Notes payable - related party		750,811			643,708
Total current liabilities		4,627,770			2,539,185
Deferred underwriting commissions		2,723,060			2,723,060
Total liabilities		7,350,830			5,262,245

Commitments and Contingencies (Note 5)
Common stock subject to possible redemption, 98,263 and 2,417,331 shares at redemption value of $9.10 and $10.56 per share as of September 30, 2024 and December 31, 2023, respectively		893,766			25,526,944

Stockholders’ deficit:
Common stock, par value $0.0001, 200,000,000 shares authorized; 2,082,825 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively		209			209
Additional paid-in capital		-			-
Accumulated deficit		(6,697,356	)		(4,728,997	)
Total stockholders’ deficit		(6,697,147	)		(4,728,788	)
Total liabilities, redeemable common stock and stockholders’ deficit	$	1,547,449		$	26,060,401

The accompanying notes are an integral part of these unaudited financial statements.

HUDSON ACQUISITION I CORP.

STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2024			2023			2024			2023
Operating expenses:
General and administrative expenses	$	306,524		$	678,504		$	776,033		$	1,237,240
Franchise tax expense		18,600			50,000			42,600			150,000
Loss from operations		(325,124	)		(728,504	)		(818,633	)		(1,387,240	)
Other income (expense):
Interest earned on marketable securities held in Trust Account		19,751			393,358			569,338			1,940,473
Interest earned on cash account		699			-			1,990			-
Loss on overpayment of franchise tax		(172,166	)		-			(172,166	)		-
Other income (expense), net		(151,716	)		393,358			399,162			1,940,473

Income (loss) before income taxes		(476,840	)		(335,146	)		(419,471	)		553,233
Provision for income taxes		(11,355	)		(108,000	)		(434,476	)		(563,000	)
Net loss	$	(488,195	)	$	(443,146	)	$	(853,947	)	$	(9,767	)

Net income attributable to common stock subject to possible redemption		8,396			285,358			134,862			1,377,473
Basic and diluted weighted-average shares outstanding, common stock subject to possible redemption		99,098			3,204,525			1,005,041			5,631,708
Basic and diluted net income per share, common stock subject to possible redemption	$	0.08		$	0.09		$	0.13		$	0.24
Net loss attributable to common stockholders		(496,591	)		(728,504	)		(988,809	)		(1,387,240	)
Weighted-average common shares outstanding, basic and diluted		2,082,825			2,082,825			2,082,825			2,082,825
Net loss per share common share, basic and diluted	$	(0.24	)	$	(0.35	)	$	(0.47	)	$	(0.67	)

(1)

The non-redeemable weighted average common shares outstanding were retroactively adjusted to account for 13,675 founder shares forfeited in connection with the partial exercise of the over-allotment.

The accompanying notes are an integral part of these unaudited financial statements.

HUDSON ACQUISITION I CORP.

STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED)

	Common Stock				Additional Paid-In		Accumulated			Stockholders’
Three Months Ended September 30, 2024	Shares		Amount		Capital		Deficit			Deficit
Balance as of June 30, 2024		2,082,825	$	209	$	—	$	(6,261,751	)	$	(6,261,542	)
Accretion of carrying value to redemption value		—		—		—		52,944			52,944
Excise tax payable attributable to redemption of common stock		—		—		—		(355	)		(355	)
Net loss		—		—		—		(488,195	)		(488,195	)
Balance as of September 30, 2024		2,082,825	$	209	$	—	$	(6,697,356	)	$	(6,697,147	)

	Common Stock				Additional Paid-In		Accumulated			Stockholders’
Three Months Ended September 30, 2023	Shares		Amount		Capital		Deficit			Deficit
Balance as of June 30, 2023		2,082,825	$	209	$	—	$	(3,036,661	)	$	(3,036,452	)
Accretion of carrying value to redemption value		—		—		—		(475,357	)		(475,357	)
Excise tax payable attributable to redemption of common stock		—		—		—		(461,700	)		(461,700	)
Net loss		—		—		—		(443,146	)		(443,146	)
Balance as of September 30, 2023		2,082,825	$	209	$	—	$	(4,416,864	)	$	(4,416,655	)

	Common Stock				Additional Paid-In		Accumulated			Stockholders’
Nine Months Ended September 30, 2024	Shares		Amount		Capital		Deficit			Deficit
Balance as of December 31, 2023		2,082,825	$	209	$	—	$	(4,728,997	)	$	(4,728,788	)
Accretion of carrying value to redemption value		—		—		—		(856,936	)		(856,936	)
Excise tax payable attributable to redemption of common stock		—		—		—		(257,476	)		(257,476	)
Net loss		—		—		—		(853,947	)		(853,947	)
Balance as of September 30, 2024		2,082,825	$	209	$	—	$	(6,697,356	)	$	(6,697,147	)

	Common Stock				Additional Paid-In		Accumulated			Stockholders’
Nine Months Ended September 30, 2023	Shares		Amount		Capital		Deficit			Deficit
Balance as of December 31, 2022		2,082,825	$	209	$	—	$	(2,477,925	)	$	(2,477,716	)
Accretion of carrying value to redemption value		—		—		—		(1,467,472	)		(1,467,472	)
Excise tax payable attributable to redemption of common stock		—		—		—		(461,700	)		(461,700	)
Net loss		—		—		—		(9,767	)		(9,767	)
Balance as of September 30, 2023		2,082,825	$	209	$	—	$	(4,416,864	)	$	(4,416,655	)

The accompanying notes are an integral part of these unaudited financial statements.

HUDSON ACQUISITION I CORP.

STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Nine Months Ended September 30,
	2024			2023
OPERATING ACTIVITIES
Net loss	$	(853,947	)	$	(9,767	)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account		(569,338	)		(1,940,473	)
Amortization on debt discount on note payable to target company		883			—
Change in operating assets and liabilities:
Prepaid expenses and other current assets		(43,252	)		94,353
Accounts payable and accrued expenses		(145,526	)		673,939
Franchise tax payable		214,766			(65,315	)
Income tax payable		177,000			563,000
Excise tax payable		257,476			—
Related party payables		—			74,063
Net cash used in operating activities		(961,938	)		(610,200	)
INVESTING ACTIVITIES
Investment of cash in Trust Account		(552,954	)		(80,000	)
Cash withdrawn from Trust Account		26,045,551			46,467,597
Net cash provided by investing activities		25,492,597			46,387,597
FINANCING ACTIVITIES
Redemption of common stock		(25,747,589	)		(46,169,982	)
Proceeds from advances from target company		1,476,882			—
Proceeds of notes payable - related party		187,103			282,000
Repayment of borrowing from related parties		(80,000	)		—
Net cash used in financing activities		(24,163,604	)		(45,887,982	)
Net increase in cash during period		367,055			(110,585	)
Cash, beginning of period		11,700			138,917
Cash, end of period	$	378,755		$	28,332
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES
Change in value of common stock subject to possible redemption	$	24,633,178		$	44,702,509
Debt discount on note payable to related party	$	23,118		$	—

The accompanying notes are an integral part of these unaudited financial statements.

HUDSON ACQUISITION I CORP.

NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

September 30, 2024

NOTE 1 — NATURE OF THE ORGANIZATION AND BUSINESS

Hudson Acquisition I Corp. (“Hudson” or the “Company”) was incorporated in the State of Delaware on January 13, 2021. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (our “Initial Business Combination”). The Company has selected December 31 as its fiscal year end.

Throughout this report, the terms “our,” “we,” “us,” and the “Company” refer to Hudson Acquisition I Corp.

As of September 30, 2024, the Company had not commenced core operations. All activity for the period from January 13, 2021 (inception) through September 30, 2024 relates to the Company’s formation and raising funds through the initial public offering (“Initial Public Offering”), which is described below, and efforts in identifying a target to consummate an Initial Business Combination. The Company will not generate any operating revenues until after the completion of an Initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement pursuant to which the Company registered its securities offered in the Initial Public Offering was declared effective on October 14, 2022. On October 18, 2022, the Company consummated its Initial Public Offering and sold 6,000,000 units (the “Units”) at a price to the public of $10.00 per Unit, resulting in total gross proceeds of $60,000,000 (before underwriting discounts and commissions and offering expenses). Each Unit consists of one share of common stock of the Company, par value $0.0001 per share (“Common Stock”) and one right to receive one-fifth (1/5) of a share of the Common Stock upon the consummation of an Initial Business Combination (“Right”).

Simultaneously with the closing of the Initial Public Offering, the Company’s sponsor, Hudson SPAC Holding LLC (the “Sponsor”) should have purchased a total of 340,000 units (the “Initial Private Placement Units”) at a price of $10.00 per the Initial Private Placement Unit (the “Private Placement”) (see Note 3).

On October 21, 2022, the Company closed the sale of 845,300 units (the “OA Units”) at $10.00 per unit as a result of the underwriters’ partial exercise of their over-allotment option (the “Overallotment Offering”) in connection with the previously announced Initial Public Offering pursuant to the underwriting agreement by and between the Company and Chardan Capital Markets, LLC dated October 14, 2022. Each OA Unit consists of one share of Common Stock of the Company, par value $0.0001 per share and one right to receive one-fifth (1/5) of one share of the Common Stock upon the consummation of an Initial Business Combination (the “Right”). Such OA Units were registered pursuant to the Company’s registration statement. As a result of the Overallotment Offering, the Company received gross proceeds of $8,453,000 (before deducting certain underwriting discount and fees), part of which was placed in the Trust Account. On October 21, 2022, simultaneously with the consummation of the Overallotment Offering, the Company completed the private placement of additional 31,500 units (the “Overallotment Private Placement Units”) pursuant to the Unit Private Placement Agreement dated October 14, 2022 by and between the Company and the Sponsor, in connection with the underwriters’ partial exercise of the over-allotment option, at a purchase price of $10.00 per Overallotment Private Placement Unit, generating gross proceeds of $315,000, a portion of which was placed in the Trust Account.

Following the closing of the Initial Public Offering and Overallotment, an amount of $69,479,795 was placed in a Trust Account in the United States maintained by Continental Stock Transfer& Trust Company, as trustee. The funds held in the Trust Account were invested only in United States government Treasury bills, bonds or notes having a maturity of 185 days or less, or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act and that invest solely in U.S. treasuries, so that the Company is not deemed to be an investment company under the Investment Company Act. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay for income or other tax obligations, the remaining proceeds will not be released from the Trust Account until the earlier of the completion of an Initial Business Combination or the Company’s liquidation. The proceeds held in the Trust Account may be used as consideration to pay the sellers of a target business with which the Company will complete the Initial Business Combination to the extent not used to pay redeeming stockholders. Any amounts not paid as consideration to the sellers of the target business may be used to finance operations of the target business.

No compensation of any kind (including finder’s, consulting or other similar fees) will be paid to any of the Company’s existing officers, directors, stockholders, or any of their affiliates, prior to, or for any services they render in order to effectuate, the consummation of the Initial Business Combination (regardless of the type of transaction that it is). However, such individuals will receive reimbursement for any out-of-pocket expenses incurred by them in connection with activities on the Company’s behalf, such as identifying potential target businesses, performing business due diligence on suitable target businesses and business combinations as well as traveling to and from the offices, plants or similar locations of prospective target businesses to examine their operations. Since the role of present management after our Initial Business Combination is uncertain, the Company has no ability to determine what remuneration, if any, will be paid to those persons after the Initial Business Combination.

The Company intends to use the excess working capital available for miscellaneous expenses such as paying fees to consultants to assist with the search for a target business and for director and officer liability insurance premiums, with the balance being held in reserve in the event due diligence, legal, accounting and other expenses of structuring and negotiating business combinations exceed estimates, as well as for reimbursement of any out-of-pocket expenses incurred by insiders, officers and directors in connection with activities on the Company’s behalf as described below.

The allocation of the net proceeds available to the Company outside of the Trust Account, along with the interest earned on the funds held in the Trust Account available to pay for income and other tax liabilities, represents the best estimate of the intended uses of these funds. In the event that the assumptions prove to be inaccurate, the Company may reallocate some of such proceeds within the above-described categories. If the estimate of the costs of undertaking due diligence and negotiating the Initial Business Combination is less than the actual amount necessary to do so, or the amount of interest available to the Company from the Trust Account is insufficient as a result of the volatile interest rate environment, the Company may be required to raise additional capital, the amount, availability and cost of which is currently unascertainable. In this event, the Company could seek such additional capital through loans or additional investments from the Sponsor or third parties. The Sponsor has agreed to loan the Company up to an aggregate of $1,000,000 to be used for working capital purposes pursuant to a Promissory Note. As of September 30, 2024, the Company had $750,811 in borrowings under the Promissory Note (see Note 4). If the Company is unable to obtain the necessary funds, the Company may be forced to cease searching for a target business and liquidate without completing the Initial Business Combination.

The Company will likely use substantially all of the net proceeds of the Initial Public Offering, including the funds held in the Trust Account, in connection with the Initial Business Combination and to pay expenses relating thereto, including the deferred underwriting discounts payable to the underwriters. To the extent that the Company’s capital stock is used in whole or in part as consideration to effect the Initial Business Combination, the proceeds held in the Trust Account which are not used to consummate an Initial Business Combination will be disbursed to the combined company and will, along with any other net proceeds not expended, be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions.

To the extent that the Company is unable to consummate an Initial Business Combination, the Company will pay the costs of liquidation from the remaining assets outside of the Trust Account. If such funds are insufficient, the Sponsor has agreed to pay the funds necessary to complete such liquidation and has agreed not to seek repayment of such expenses.

If no business combination is completed prior to the mandatory liquidation date, the proceeds then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes (less $100,000 of interest to pay dissolution expenses), will be used to fund the redemption of the public shares. The Sponsor, directors, director nominees and officers will enter into a letter agreement with the Company, pursuant to which they have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete the Initial Business Combination within such time period.

In connection with the shares purchased by the founders, the founders waive any and all right, title, interest or claim of any kind in or to any distributions by the Company from the Trust Account which will be established for the benefit of the Company’s public stockholders and into which substantially all of the proceeds of the Initial Public Offering will be deposited (the “Trust Account”), in the event of a liquidation of the Company upon the Company’s failure to timely complete an Initial Business Combination.

Extension Amendment

On July 17, 2023, the Company held the Special Meeting. On June 28, 2023, the record date for the Special Meeting, there were 8,928,125 shares of common stock outstanding, in which 8,556,625 were entitled to vote at the Special Meeting, approximately 84% of which were represented in person or by proxy at the Special Meeting. The stockholders approved the proposal to amend the Company’s Certificate of Incorporation to give the Company the option to extend the date by which the Company must effect a Business Combination beyond July 18, 2023 up to nine (9) times for an additional (1) month each time to April 18, 2024 upon the deposit into the Trust Account of $80,000 for each calendar month. This amendment increased the time the Company has to consummate an Initial Business Combination from the original maximum amount of 15 months to 18 months from the Initial Public Offering date. In connection with the votes to approve the proposals above, the holders of 4,427,969 shares of common stock of the Company properly exercised their right to redeem their shares for approximately $10.43 per share. Following such redemptions, $46,169,982 was withdrawn from the trust account on July 25, 2023 and 2,417,331 Public Shares remained outstanding.

On July 17, 2023, the Company filed a certificate of amendment (the “Certificate of Amendment”) to the Company’s Second Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware. The Certificate of Amendment amends the Certificate of Incorporation to (i) give the Company the option to extend the date by which the Company must effect a Business Combination beyond July 18, 2023 up to nine (9) times for an additional (1) month each time to April 18, 2024 upon the deposit into the Trust Account of $80,000 for each calendar month and (ii) eliminate the limitation that the Company may not redeem public shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Securities Exchange Act of 1934 of less than $5,000,001.

On April 17, 2024, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware. The Certificate of Amendment amends the Certificate of Incorporation to (i) give the Company the option to extend the date by which the Company must effect a Business Combination beyond April 18, 2024, up to nine (9) times for an additional (1) month each time to January 18, 2025, upon the deposit into the Trust Account of $25,000 for each calendar month and (ii) to remove the geographic limitations for a Business Combination., which requires the deletion of Section J of the Sixth Article in the Charter: “J. At no time, the Corporation shall undertake a Business Combination with any entity being based in or having the majority of its operations in China (including Hong Kong and Macau).” In connection with the vote to approve the Extension Amendment, the holders of 2,315,868 shares of Public Shares properly exercised their right to redeem their shares (and did not withdraw their redemption) for cash at a redemption price of approximately $11.10 per share, for an aggregate redemption amount of $25,712,132. Following such redemptions, 101,463 Public Shares remained outstanding.

On July 5, 2024, the Company held the Special Meeting. On June 4, 2024, the record date for the Special Meeting, there were 1,816,463 shares of common stock outstanding, and 2,184,288 shares of common stock and units entitled to be voted at the Special Meeting, approximately 98% of which were represented in person or by proxy at the Special Meeting. The stockholders approved the proposal to amend the Company’s Second Amended and Restated Certificate of Incorporation pursuant to an amendment to the Charter in the form set forth in Annex A to the Proxy Statement to extend the date by which the Company must effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses from January 18, 2025, up to nine (9) times for an additional one (1) month each time to October 18, 2025, and will no longer require monthly deposits into the Trust Account as of July 5, 2024. The stockholders also approved an amendment to the Charter to amend the Company’s Second Amended and Restated Certificate of Incorporation pursuant to the Charter in the form set forth in forth in Annex B to the Proxy Statement to amend Article Sixth of the Charter by adding a definition of IPO Rights, and Sixth (A)(ii) by adding “and IPO Rights” and (“and rights”) to read: “or (ii) provide its holders of IPO Shares and IPO Rights with the opportunity to sell their shares and rights to the Corporation by means of a tender offer (“Tender Offer”)”.

On July 10, 2024, the Company filed a Certificate of Amendment to the Company’s Second Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware. The Certificate of Amendment amends the Certificate of Incorporation to (i) give the Company the option to extend the date by which the Company must effect a Business Combination beyond January 18, 2025, up to nine (9) times for an additional (1) month each time to October 18, 2025, and will no longer require monthly deposits into the Trust Account as of July 5, 2024.

In connection with the vote to approve the Extension Amendment, the holders of 3,200 shares of Public Shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.08 per share, for an aggregate redemption amount of $35,457. Following such redemptions, 98,263 Public Shares remained outstanding.

Liquidity and Capital Resources

As of September 30, 2024, the Company had $378,755 in its operating bank account and a working capital deficit of $2,250,765, which excludes franchise tax payable, income tax payable, and excise tax payable. The Company may raise additional capital through loans or additional investments from the Sponsor or its stockholders, officers, directors, or third parties. The Company’s officers and directors and the Sponsor may but are not obligated to (except as described above), loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Based on the foregoing, the Company believes it will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or at least one year from the date that the financial statements were issued.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until October 18, 2025, assuming the monthly extension requirements are satisfied, to consummate a Business Combination (the “Combination Period”). Following the first extension, the Company was able to extend the date by which an Initial Business Combination must be consummated beyond July 18, 2023 up to nine times for an additional one month each time to April 18, 2024 upon the deposit into the Trust Account of $80,000 in each calendar month. Following the second extension, the Company was able to extend the date by which an Initial Business Combination must be consummated beyond April 18, 2024 up to an additional nine times for an additional one month each time to January 18, 2025 upon the deposit into the Trust Account of $25,000 each calendar month. Following the third extension, the Company is able to extend the date by which an Initial Business Combination must be consummated beyond January 18, 2025, up to an additional nine times for an additional one month each time to October 18, 2025, with extension payments in connection with the first and second extension ending on July 5, 2024. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by October 18, 2025, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to complete a Business Combination prior to the end of the Combination Period. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the end of the Combination Period.

Nasdaq Compliance

On July 23, 2024, the Company received a notice from The NASDAQ Stock Market (“Nasdaq”) that its securities will be delisted from The Nasdaq Global Market. On December 15, 2023, the staff of Nasdaq (the “Staff”) notified the Company that the market value of its listed securities had been below the minimum $50,000,000 required for continued listing as set forth in Listing Rule 5450(b)(2)(A) (the “Rule”) for the previous 30 consecutive trading days. Therefore, in accordance with Listing Rule 5810(c)(3)(C), the Company was provided 180 calendar days, or until June 12, 2024, to regain compliance with the Rule. However, the Company did not regain compliance with the Rule.

In addition, based on the Staff’s review of the Company’s Definitive Proxy Statement filed June 24, 2024, the Staff determined that the Company does not comply Listing Rule 5450(b)(2)(A), requiring a minimum 1,100,000 Publicly Held Shares, and Listing Rule 5450(b)(2)(C), requiring a minimum of $15 million Market Value of Publicly Held Shares requirement.

Based on the Company’s equity information as of July 22, 2024, the Company does not comply with the requirement for continued listing on the Nasdaq Capital Market under Listing Rule 5550. Additionally, the Staff has concerns that the Company may also no longer comply with the minimum 400 Total Holders requirement of Listing Rule 5450(a)(2) due to the substantial number of shareholder redemptions and low number of shares remaining outstanding. Finally, the Company failed to timely file its Form 10-K for the year ended December 31, 2023, and its Form 10-Q for the period ended March 31, 2024, as required by Listing Rule 5250(c)(1). Accordingly, these matters each serve as additional and separate basis for delisting.

Under Listing Rule 5810, a company that fails to comply with the continued listing requirements is normally afforded a compliance period or the ability to submit a plan of compliance in order to be granted time to regain compliance. However, given that the Company fails to comply with multiple continued listing requirements by such significant margins, and that each of these requirements is related to the security’s liquidity necessary to maintain a fair and orderly market, the Staff has determined to apply more stringent criteria pursuant to its discretionary authority set forth in Listing Rule 5101. Accordingly, the Staff has concluded that continued listing is inappropriate and to delist the Company’s securities in order to maintain the quality of and public confidence in the Nasdaq market, to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, and to protect investors and the public interest.

Accordingly, the Staff has determined that the Company’s securities will be delisted from The Nasdaq Global Market. In that regard, unless the Company requests an appeal of this determination by July 30, 2024, trading of the Company’s ordinary shares, warrants, and units will be suspended at the opening of business on August 1, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market. The Company may appeal the Staff’s determination to a Hearings Panel, pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series.

In response to the Nasdaq delisting notice, the Company has taken the following actions:

●

On July 23, 2024, the Company applied to transfer from Nasdaq Global Market to Nasdaq Capital Market.

●

On July 24, 2024, the Company requested a hearing and paid the $20,000 fee for the hearing.

●

On July 24, 2024, the Company received hearing instructions from Nasdaq, and has secured the hearing date for August 22, 2024.

The Company submitted its written submission to Nasdaq on August 2, 2024.

The Company has also confirmed with Nasdaq that, in the event that the Company is delisted, the delisting will not preclude the combined entity (the de-SPAC entity) from receiving initial listing approval for listing on the Nasdaq Stock Market. In fact, the combined entity will be held to the same quantitative initial listing standards irrespective of the listing status of the SPAC as a business combination resulting in a change of control and/or a de-SPAC business combination necessitates initial listing approval.

The Company filed its Form 10-K for the year ended December 31, 2023 on July 23, 2024. The Company filed its Form 10-Q for the three months ended March 31, 2024 on August 2, 2024.

On August 12, 2024, the Company received a notification from Nasdaq that it has cured its filing discrepancies under Listing Rule 5250(c)(1).

The Company has come up with a series of action plans to regain compliance, and presented its case to Nasdaq Panel on its hearing on August 22, 2024.

In connection with the foregoing, and the information presented to the Nasdaq Panel, Nasdaq issued a letter to the Company on September 27, 2024, which stated, in pertinent part, that based on the information presented to the panel, the Company’s request for an exception to complete its plan of compliance has been granted. Thus, the Panel has granted the Company’s request for continued listing on the Exchange, subject to the following:

On or before October 4, 2024, the Company shall provide a detailed update to the Panel on the status of its merger with Aiways and the status of all completed transfers of Founder Shares and Private Placement Shares. Additionally, the Company shall provide the Panel and Nasdaq Listing Qualifications Staff with copies of all agreements related to the share transfers. The Panel requests Nasdaq Staff to review the agreements related to the shares transfer and to indicate to the Panel whether any additional deficiencies arise from the transactions. The Company must promptly respond to any requests from Nasdaq Staff for additional information. To date, the Company has completed this first request from Nasdaq.

On or before November 22, 2024, the Company must complete the transfer of the remainder of the Founder Shares and Private Placement Shares and shall provide the Panel with a list of all transferees, a description of how the Company identified the transferee, and a detailed description of any differences in the agreements between each of these transfers and with the agreements for the initial transfers. The Company is in the process of completing this request, and expects to complete this request on or before November 22, 2024.

On or before January 20, 2025, the Company must complete the proposed Business Combination and demonstrate, by means of a listing approval from Nasdaq Staff, compliance with IM-5101-2 and all applicable initial listing requirements for listing the combined company on the Capital Market. The Company expects to complete the proposed Business Combination on or before January 20, 2025.

The Company is advised that January 20, 2025, represents the full extent of the Panel’s discretion to grant continued listing while the Company is non-compliant with Listing Rule IM-5101-2.

NOTE 2 — BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2023, as filed with the SEC on July 23, 2024. The interim results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2024 and December 31, 2023.

Marketable Securities Held in Trust Account

The Company classifies its Marketable Securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying condensed balance sheet and adjusted for the amortization or accretion of premiums or discounts. When the Company’s investments held in the Trust Account are comprised of money market securities, the investments are classified as trading securities. Gains and losses resulting from the change in fair value of these securities is included in interest earned on investments held in the Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

Offering Costs

Offering costs consist of professional fees, filing, regulatory and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid-in capital and accumulated deficit.

As of September 30, 2024 and December 31, 2023, the common stock subject to possible redemption reflected on the condensed balance sheet is reflected in the following table:

Common stock subject to possible redemption, December 31, 2022	$	69,786,334
Less:
Redemption of common stock in connection with Trust Extension		(46,169,982	)
Add:
Accretion of carrying value to redemption value		1,910,592
Common stock subject to possible redemption, December 31, 2023	$	25,526,944
Less:
Redemption of common stock		(25,747,589	)
Add:
Accretion of carrying value to redemption value		1,114,411
Common stock subject to possible redemption, September 30, 2024		893,766

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Net (Loss) Income per Share of Common Stock

The Company has two outstanding classes of shares, which are referred to as redeemable common stock and non-redeemable common stock. Earnings and losses are shared pro rata between the two classes of stock. The 98,263 redeemable shares of common stock for which the outstanding Public Rights are exercisable were excluded from diluted earnings and losses per share for the three and nine months ended September 30, 2024 and 2023, respectively because they are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net (loss) income per share of common stock is the same as basic net (loss) income per share of common stock for the period. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per share for each class of shares.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2024			2023			2024			2023
Common stock subject to possible redemption
Numerator: Earnings allocable to common stock subject to redemption
Interest earned on marketable securities held in Trust Account, net of taxes	$	8,396		$	285,358		$	134,862		$	1,377,473
Net income attributable to common stock subject to possible redemption	$	8,396		$	285,358		$	134,862		$	1,377,473
Denominator: Weighted average common shares subject to redemption
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption		99,098			3,204,525			1,005,041			5,631,708
Basic and diluted net income per share, common stock subject to possible redemption	$	0.08		$	0.09		$	0.13		$	0.24

Non-Redeemable common stock
Numerator: Net loss minus net earnings - Basic and diluted
Net loss	$	(488,195	)	$	(443,146	)	$	(853,947	)	$	(9,767	)
Less: net income attributable to common stock subject to redemption		(8,396	)		(285,358	)		(134,862	)		(1,377,473	)
Net loss attributable to non-redeemable common stock	$	(496,591	)	$	(728,504	)	$	(988,809	)	$	(1,387,240	)
Denominator: Weighted average non-redeemable common shares
Weighted-average non-redeemable common shares outstanding, basic and diluted		2,082,825			2,082,825			2,082,825			2,082,825
Basic and diluted net loss per share, non-redeemable common stock	$	(0.24	)	$	(0.35	)	$	(0.47	)	$	(0.67	)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of September 30, 2024, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

●

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Unit Purchase Option

At the closing of the Initial Public Offering, the Company sold to the underwriter, for an aggregate of $100, an option (the “UPO”) to purchase 57,500 Units, including over-allotment. The over-allotment option was not exercised in full on October 21, 2022, therefore, the UPO was reduced pro-rata to 57,044 Units, and had a fair value of $25,099. The UPO will be exercisable at any time, in whole or in part, between the close of the business combination and fifth anniversary of the date of the Initial Public Offering at a price per Unit equal to $11.50 (or 115% of the public unit offering price). The Company accounts for the Unit Purchase Option, inclusive of the receipt of $100 cash payment, as an offering cost of the Initial Public Offering resulting in a charge directly to stockholders’ deficit. The Unit Purchase Option and such units purchased pursuant to the Unit Purchase Option, as well as the common stock underlying such units, the rights included in such units, the shares of common stock that are issuable for the rights included in such units, have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1). The Unit Purchase Option grants to holders demand and “piggy back” rights for periods of five and seven years, respectively, from the effective date of the registration statement with respect to the registration under the Securities Act of the securities directly and indirectly issuable upon exercise of the Unit Purchase Option. The Company will bear all fees and expenses attendant to registering the securities, other than underwriting commissions which will be paid for by the holders themselves. The exercise price and number of units issuable upon exercise of the Unit Purchase Option may be adjusted in certain circumstances including in the event of a stock dividend, or the Company’s recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted for issuances of common stock at a price below its exercise price.

Representative Shares

The Company agreed to issue to the underwriter at the closing of the Initial Public Offering up to 136,906 representative shares (“Representative Shares”), due to the partial exercise of the over-allotment, which will be issued upon the completion of the Initial Business Combination. The representative shares had an initial fair value of $327,205 and is included as deferred underwriting commissions in the accompanying balance sheets.

Recent Accounting Pronouncements

In August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis, with early adoption permitted for fiscal years beginning after December 15, 2020. The Company does not expect the adoption of this ASU would have a material effect on the Company’s financial statements.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. ASU 2023-09 will become effective for annual periods beginning after December 15, 2024. The Company does not expect the adoption of this ASU would have a material effect on the Company’s financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statement.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic, Russia-Ukraine war, and the Middle East geopolitical tension on the economy and the capital markets and has concluded that, while it is reasonably possible that such events could have negative effects on the Company’s financial position and outlook for an Initial Business Combination, the specific impacts are not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

The current challenging economic climate may lead to adverse changes in cash flows, working capital levels and/or debt balances, which may also have a direct impact on the Company’s future operating results and financial position after any such Initial Business Combination in the future. The ultimate duration and magnitude of the impact and the efficacy of government interventions on the economy and the financial effect on the Company is not known at this time. The extent of such impact will depend on future developments, which are highly uncertain and not in the Company’s control.

NOTE 3 — INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, on October 18, 2022, the Company sold 6,000,000 Units at a price to the public of $10.00 per Unit, resulting in total gross proceeds of $60,000,000 (before underwriting discounts and commissions and offering expenses). Each Unit consists of one share of Common Stock of the Company, par value $0.0001 per share and one Right to receive one-fifth (1/5) of a share of the Common Stock upon the consummation of an Initial Business Combination.

Simultaneously with the closing of the Initial Public Offering, the Sponsor should have purchased a total of 340,000 Initial Private Placement Units at a price of $10.00 per the Private Placement. However, on October 18, 2022, simultaneously with the consummation of the Initial Public Offering, the Sponsor partially consummated the Private Placement by subscribing to 238,500 Private Placement Units instead of the full Initial Private Placement Units, generating gross proceeds of approximately $2,385,000 instead of the full $3,400,000, part of the proceeds of which were placed in the Trust Account. The Trust Account was nonetheless fully-funded. On November 30, 2022, the Company received an additional remittance of $515,000 underlying the Sponsor’s purchase of the Private Placement Units, reducing the balance to $500,000. Additionally, on December 1, 2022, the Sponsor applied the outstanding balance on the Promissory Note of $500,000 towards the remaining stock subscription balance, which fully funded the Sponsor’s purchase of the Private Placement Units. No underwriting discounts or commissions were paid with respect to the Private Placement. The Purchased Private Placement Units are identical to the Units, except that (a) the Purchased Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of the Company’s Initial Business Combination except to permitted transferees and (b) the shares and rights included as a component of the Purchased Private Placement Units, so long as they are held by the Sponsor or its permitted transferees, will be entitled to registration rights, respectively. If the Company does not complete the Initial Business Combination before the mandatory liquidation date, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the public shares (subject to the requirements of applicable law) and the rights included as part of the Private Placement Units will expire worthless.

On October 21, 2022, the Company closed the sale of 845,300 OA Units at $10.00 per unit as a result of the underwriters’ partial exercise of their over-allotment option in connection with the previously announced Initial Public Offering pursuant to the underwriting agreement by and between the Company and Chardan Capital Markets, LLC dated October 14, 2022. Each OA Unit consists of one share of Common Stock of the Company, par value $0.0001 per share and one right to receive one-fifth (1/5) of one share of the Common Stock upon the consummation of an Initial Business Combination. Such OA Units were registered pursuant to the Company’s registration statement. As a result of the Overallotment Offering, the Company received gross proceeds of $8,453,000 (before deducting certain underwriting discount and fees), part of which was placed in the Trust Account. On October 21, 2022, simultaneously with the consummation of the Overallotment Offering, the Company completed the private placement of additional 31,500 Private Placement Units pursuant to the Unit Private Placement Agreement dated October 14, 2022 by and between the Company and the Sponsor, in connection with the underwriters’ partial exercise of the over-allotment option, at a purchase price of $10.00 per Overallotment Private Placement Unit, generating gross proceeds of $315,000, a portion of which was placed in the Trust Account.

NOTE 4 — RELATED PARTY TRANSACTIONS

Private Placement Units

Simultaneously with the closing of the Initial Public Offering, the Sponsor should have purchased a total of 340,000 units (the “Initial Private Placement Units”) at a price of $10.00 per the Initial Private Placement Unit (the “Private Placement”) (see Note 3). On October 21, 2022, the Company closed the sale of 845,300 units (the “OA Units”) at $10.00 per unit as a result of the underwriters’ partial exercise of their over-allotment option (the “Overallotment Offering”) in connection with the previously announced Initial Public Offering pursuant to the underwriting agreement by and between the Company and Chardan Capital Markets, LLC dated October 14, 2022. Each OA Unit consists of one share of Common Stock of the Company, par value $0.0001 per share and one right to receive one-fifth (1/5) of one share of the Common Stock upon the consummation of an Initial Business Combination (the “Right”). Such OA Units were registered pursuant to the Company’s registration statement. As a result of the Overallotment Offering, the Company received gross proceeds of $8,453,000 (before deducting certain underwriting discount and fees), part of which was placed in the Trust Account. On October 21, 2022, simultaneously with the consummation of the Overallotment Offering, the Company completed the private placement of additional 31,500 units (the “Overallotment Private Placement Units”) pursuant to the Unit Private Placement Agreement dated October 14, 2022 by and between the Company and the Sponsor, in connection with the underwriters’ partial exercise of the over-allotment option, at a purchase price of $10.00 per Overallotment Private Placement Unit, generating gross proceeds of $315,000, a portion of which was placed in the Trust Account.

Promissory Note — Related Party

On April 5, 2021, as further amended on April 28, 2021 and September 8, 2022, the Company entered into a promissory note with the Sponsor for principal amount up to $1,000,000. The promissory note is non-interest bearing and matures on the earlier of: (i) the date of the consummation of the Company’s Initial Business Combination or (ii) the date of the liquidation of the Company. The principal balance may be prepaid at any time. A maximum of $1,000,000 of such loans may be converted into Units, at the price of $10.00 per Unit at the option of the Sponsor.

On May 6, 2021, the Company made a drawdown of $300,000 on the promissory note. On April 15 and August 19, 2022, the Company made additional drawdowns of $100,000 and $100,000 on the promissory note, respectively.

On December 1, 2022, the Sponsor applied the outstanding balance on the Promissory Note of $500,000 towards the payments for Private Placement Units.

On July 20, 2023, the Company and the Sponsor amended and restated the promissory note, dated as of April 5, 2021, providing for loans up to $1,000,000 in the aggregate. The promissory note bears no interest and all unpaid principal under the promissory note will be due and payable in full upon the earlier of (i) the date of the consummation of the Company’s Initial Business Combination or (ii) the date of the liquidation of the Company. At the election of the Sponsor, up to $1.0 million of the loans under the promissory note may be settled in Units at a conversion rate of $10.00 per Unit, with each private unit comprised of one share of common stock of the Company and one right to one-fifth of a share of the Company’s common stock. As of September 30, 2024 and December 31, 2023, $750,811 and $643,708, respectively, was outstanding under the promissory note.

In connection with the approval of the extension amendment proposal, on July 18, 2023, the Sponsor entered into a non-interest bearing, unsecured promissory note issued by the Company in favor of the Sponsor (the “Extension Note”), providing for loans up to the aggregate principal amount of $720,000. On July 24, 2023, pursuant to the Second Amended and Restated Certificate of Incorporation, as amended by the Certificate of Amendment, $80,000 was deposited into the Trust Account for a one-month extension. $80,000 will be deposited into the Trust Account each month the Company determines to extend the date by which it must consummate an Initial Business Combination. The Company elected to extend such date until April 18, 2024, therefore, an aggregate deposit of $720,000 of the proceeds of the Extension Note will be made into the Trust Account. The Extension Note bears no interest and all unpaid principal under the Extension Note will be due and payable in full upon the earlier of (i) the date of the consummation of the Company’s Initial Business Combination or (ii) the date of the liquidation of the Company. The Extension Note balance was $240,000 as of September 30, 2024 and December 31, 2023, respectively.

Administrative Support Agreement

Commencing on October 14, 2022, the Company has agreed to pay the Sponsor or its affiliate a total of $20,000 per month for office space, utilities, and secretarial and administrative support. Upon completion of our Initial Business Combination or our liquidation, we will cease paying these monthly fees. For the three months ended September 30, 2024 and 2023, the Company incurred $60,000 and $60,000, respectively, on administrative support fees. For the nine months ended September 30, 2024 and 2023, the Company incurred $180,000 and $180,000, respectively, on administrative support fees.

NOTE 5 — COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the (i) the Founder Shares, which were issued in a private placement prior to the closing of the Initial Public Offering, and (ii) Private Placement Units, which were sold simultaneously with the closing of the Initial Public Offering, are entitled to registration rights pursuant to a registration rights agreement signed prior to or on the effective date of the Initial Public Offering. The holders of the majority of these securities are entitled to make up to three demands that the Company register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which the Founder Shares are to be released from escrow. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our consummation of our Initial Business Combination.

Underwriting Agreement

The underwriters received a cash underwriting discount of $0.20 per Unit, or $1,369,060 and were paid offering expenses of $100,000 upon closing of the Initial Public Offering including the overallotment. As of March 31, 2024 and December 31, 2023, the Company had recorded deferred underwriting commissions of $2,723,060 payable only upon completion of the Initial Business Combination, which consisted of commissions and representative shares issuable in connection with the Initial Public Offering. The Company agreed to issue to the underwriter at the closing of the Initial Public Offering up to 136,906 representative shares, due to the partial exercise of the over-allotment, which will be issued upon the completion of the Initial Business Combination. The representative shares had an initial fair value of $327,205.

Excise Tax

The Inflation Reduction Act of 2022 imposes a 1% Excise Tax on the repurchase of corporate stock by a publicly traded U.S. corporation following December 31, 2022. For purposes of the Excise Tax, a repurchase will generally include redemptions, corporate buybacks and other transactions in which the corporation acquires its stock from a shareholder in exchange for cash or property, subject to exceptions for de minimis transactions and certain reorganizations.

As a result, subject to certain rules, the Excise Tax will apply to any redemption by a U.S.-domiciled SPAC taking place after December 31, 2022, including redemptions (i) by shareholders in connection with the SPAC’s Initial Business Combination or a proxy vote to extend the lifespan of the SPAC, (ii) by SPACs if the SPAC does not complete a de-SPAC transaction within the required time set forth in its constituent documents, or (iii) in connection with the wind-up and liquidation of the SPAC. The financial responsibility for such Excise Tax resides with the Company and the Sponsor. This amount of 1% has been included in the accompanying financial statements.

At this time, it has been determined that the IR Act tax provisions have an impact to the Company’s accompanying financial statements as there were redemptions by the public stockholders in 2023 and 2024; as a result, the Company recorded $719,176 and $461,700 excise tax liability as of September 30, 2024 and December 31, 2023, respectively. The Company will continue to monitor for updates to the Company’s business along with guidance issued with respect to the IR Act to determine whether any adjustments are needed to the Company’s tax provision in future periods.

During the second quarter of 2024, the IRS issued final regulations with respect to the timing and payment of the excise tax. Pursuant to those regulations, the Company would need to file a return and remit payment for any liability incurred during the period from January 1, 2023 to December 31, 2023 on or before October 31, 2024.

The Company is currently evaluating its options with respect to payment of this obligation. If the Company is unable to pay its obligation in full, it will be subject to additional interest and penalties which are currently estimated at 10% interest per annum and a 5% underpayment penalty per month or portion of a month up to 25% of the total liability for any amount that is unpaid from November 1, 2024 until paid in full.

Unit Purchase Option

Agreement with Aiways Automobile Europe GmbH

On May 14, 2024, the Company set forth the terms of a proposed business combination transaction, between HUDA and Aiways Automobile Europe GmbH (“Aiways”) via a Letter Agreement. In connection with the proposed transaction, on May 18, 2024, the Company executed a non-interest bearing promissory note agreement with Aiways. In the agreement, Aiways agreed to issue a promissory note in the amount of $1,000,000 to the Company. The note should be repaid by the Company on or before the date on which the Company consummates an initial business combination at its election and without penalty. The Company shall repay Aiways either: (i) in cash payment that equals to the paid principal outstanding, or (ii) the Company’s common stock shares, at a fixed conversion price of $10 per share, at Aiways’ choice. Shares issuable shall be identical to the Company’s existing common stock shares. Aiways made a payment of $1,000,000 to the Company on June 30, 2024. The Company recorded the receipt of the payment as a note payable to target company for de-SPAC transaction in the accompanying balance sheets.

On August 31, 2024, the Company executed a non-interest bearing promissory note agreement with Aiways. Pursuance to the agreement, Aiways agreed to issue a promissory note in the amount of $500,000 to the Company. The note should be repaid by the Company on or before the date on which the Company consummates an initial business combination at its election and without penalty. The Company shall repay Aiways either: (i) in cash payment that equals to the paid principal outstanding, or (ii) the Company’s common stock shares, at a fixed conversion price of $10 per share, at Aiways’ choice. Shares issuable shall be identical to the Company’s existing common stock shares. On September 25, 2024, the Company received the cash proceeds from Aiways in the amount of $476,882 which represented a principal of $500,000 and an original issuing discount of $23,118. The original issuing discount is recorded in balance sheet in a contra liability account net against the advance from target company for de-SPAC transaction. The original issuing discount will be amortized over the term of the loan. An amortization expense of $883 was recorded for the three and nine months ended September 30, 2024. The principal of $500,000 was recorded in the balance sheet in the advance from target company for de-SPAC transaction account.

As of September 30, 2024, the balance in the advance from target company for de-SPAC transaction account was $1,477,765.

NOTE 6 — COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION

The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets in accordance with ASC 480, “Distinguishing Liabilities from Equity”.

NOTE 7 — STOCKHOLDERS’ DEFICIT

Authorized Shares

The total number of shares of capital stock, par value of $0.0001 per share, which the Company is authorized to issue is 200,000,000 shares of common stock. Except as otherwise required by law, the holders of the Common Stock shall exclusively possess all voting power with respect to the Company.

Founder’s Shares

At inception, January 13, 2021, the Company issued 2,875,000 Founder Shares of common stock for total receivable of approximately of $25,000 received on May 11, 2021. These Founder Shares included up to 375,000 shares of which were subject to forfeiture by the stockholder if the underwriters did not fully exercise their over-allotment option. On December 10, 2021, pursuant to the Underwriter Addendum, the aggregate number of Founder Shares were reduced to 1,725,000. All share and per-share amounts have been retroactively restated to reflect the share surrender. In connection with the partial exercise of the over-allotment option on October 21, 2022, 13,675 Founder Shares were forfeited. The remaining Founder Shares represent 20% of the outstanding shares after the Initial Public Offering. As of September 30, 2024 and December 31, 2023, there were 2,082,825 shares outstanding.

Initial Public Offering

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased a total of 340,000 Initial Private Placement Units at a price of $10.00 per Unit.

On October 21, 2022, simultaneously with the consummation of the Overallotment Offering, the Company completed the private placement of additional 31,500 units (the “Overallotment Private Placement Units”) pursuant to the Unit Private Placement Agreement dated October 14, 2022 by and between the Company and the Sponsor, in connection with the underwriters’ partial exercise of the over-allotment option, at a purchase price of $10.00 per Overallotment Private Placement Unit, generating gross proceeds of $315,000, a portion of which was placed in the Trust Account.

Rights

Except in cases where the Company is not the surviving company in the Initial Business Combination, each holder of a public right will automatically receive one-fifth (1/5) of a share of common stock upon consummation of the Initial Business Combination. In the event the Company is not be the surviving company upon completion of the Initial Business Combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-fifth (1/5) of a share underlying each right upon consummation of the Initial Business Combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Delaware General Corporation Law. As a result, holders of Rights must hold such Rights in multiples of 5 in order to receive shares for all of the holder’s rights upon closing of an Initial Business Combination. If the Company is unable to complete an Initial Business Combination within the required time period and the public shares are redeemed for the funds held in the Trust Account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless.

NOTE 8 — FAIR VALUE MEASUREMENTS

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description:	Level		September 30, 2024		December 31, 2023
Assets:
Cash and marketable securities held in Trust Account		1	$	1,109,108	$	26,036,953

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were no transfers to or from Level 3 assets or liabilities during the three and nine months ended September 30, 2024 and 2023.

NOTE 9 — SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the date the financial statements are available to be issued. Other than below, there are no subsequent events identified that would require disclosure in the financial statements.

On October 3, 2024, the Company paid down the promissory notes to its Sponsor in the amount of $80,000. The balance of notes payable to related party was reduced to $670,811 subsequently.

On October 29, 2024, the Company entered into a thirty-six-month operating motor vehicle lease agreement with Manhattan Luxury Automobiles Inc. for a 2024 Lexus GX 550 vehicle. The lease commenced on October 29, 2024 with a monthly lease payment of $1,200. The Company intends to return the leased vehicle to the lessor upon the completion of business combination.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Special Note Regarding Forward-Looking Statements

References in this report (this “Quarterly Report”) to “we,” “us” or the “Company” refer to Hudson Acquisition I Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Hudson SPAC Holding, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company formed under the laws of the State of Delaware on January 13, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. We intend to effectuate our Initial Business Combination using cash from the proceeds of the initial public offering, our capital stock, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete an Initial Business Combination will be successful.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception through September 30, 2024 were organizational activities and those necessary to prepare for our initial public offering and identifying a target for an Initial Business Combination. We do not expect to generate any operating revenues until after the completion of our Initial Business Combination. We generate non-operating income in the form of interest income on marketable securities held in the trust account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the nine months ended September 30, 2024, we had a net loss of $853,947, which consisted of interest earned on marketable securities held in the trust account of $569,338 and interest earned on the operating cash account of $1,990, offset by general and administrative expenses of $776,033, franchise tax expense of $42,600, loss on overpayment of franchise tax of 172,166, and provision for income taxes of $434,476.

For the nine months ended September 30, 2023, we had net loss of $9,767, which consisted of interest earned on marketable securities held in the trust account of $1,940,473, offset by general and administrative expenses of $1,237,240, franchise tax expense of $150,000, and provision for income taxes of $563,000.

For the three months ended September 30, 2024, we had a net loss of $488,195, which consisted of interest earned on marketable securities held in the trust account of $19,751 and interest earned on the operating cash account of $699, offset by general and administrative expenses of $306,524, franchise tax expense of $18,600, loss on overpayment of franchise tax of 172,166, and provision for income taxes of $11,355.

For the three months ended September 30, 2023, we had a net loss of $443,146, which consisted of interest earned on marketable securities held in the trust account of $393,358 , offset by general and administrative expenses of $678,504, franchise tax expense of $50,000, and provision for income taxes of $108,000.

Factors That May Adversely Affect Our Results of Operations

Our results of operations and our ability to complete an Initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an Initial Business Combination.

Liquidity and Capital Resources

On October 18, 2022, we consummated our Initial Public Offering of 6,000,000 Units, at a price to the public of $10.00 per Unit, resulting in total gross proceeds of $60,000,000. On October 18, 2022, simultaneously with the consummation of the Initial Public Offering, our Sponsor partially consummated the Private Placement by subscribing to 238,500 units instead of the full Initial Private Placement Units, generating gross proceeds of approximately $2,385,000 instead of the full $3,400,000, part of the proceeds of which were placed in the Trust Account. The Trust Account was nonetheless fully funded.

On October 21, 2022, we closed the sale of 845,300 Over-allotment Units at $10.00 per unit as a result of the underwriters’ partial exercise of their Over-allotment Option in connection with the previously announced Initial Public Offering pursuant to the underwriting agreement by and between us and Chardan Capital Markets, LLC dated October 14, 2022. Each Over-allotment Unit consists of one share of Common Stock of the Company, par value $0.0001 per share and one Right to receive one-fifth (1/5) of one share of the Common Stock upon the consummation of an Initial Business Combination. Such Over-allotment Units were registered pursuant to our registration statement. As a result of the Overallotment Offering, we received gross proceeds of $8,453,000 (before deducting certain underwriting discount and fees), part of which was placed in the Trust Account. On October 21, 2022, simultaneously with the consummation of the Overallotment Offering, we completed the Overallotment Private Placement of additional 31,500 units pursuant to the Unit Private Placement Agreement dated October 14, 2022 by and between us and our Sponsor, in connection with the underwriters’ partial exercise of the over-allotment option, at a purchase price of $10.00 per Overallotment Private Placement Unit, generating gross proceeds of $315,000, a portion of which was placed in the Trust Account.

For the nine months ended September 30, 2024, cash used in operating activities was $961,938, consisting of a net loss of $853,947, interest received on marketable securities held in the Trust Account of $569,338, and an increase in prepaid expenses and other current assets of $43,252, and a decrease in accounts payable and accrued expenses of $145,526, that were partially offset by the increase in franchise tax payable of $214,766, income tax payable of $177,000, excise tax payable of $257,476 and amortization on debt discount on notes to target company of $883.

For the nine months ended September 30, 2023, cash used in operating activities was $610,200, consisting of a net loss of $9,767, interest received on marketable securities held in the Trust Account of $1,940,473, and an decrease in franchise tax payable of $65,315, that were partially offset by the decrease in prepaid expenses and other current assets of $94,353, plus an increase in accounts payable and accrued expenses of $673,939, income tax payable of $563,000, and related party payable of $74,063.

For the nine months ended September 30, 2024, cash provided by investing activities was $25,492,597, consisting of cash withdrawn from the Trust Account of $26,045,551, that was partially offset by an investment of cash in Trust Account of $552,954.

For the nine months ended September 30, 2023, cash provided by investing activities was $46,387,597, consisting of cash withdrawn from the Trust Account of $46,467,597, that was partially offset by an investment of cash in Trust Account of $80,000.

For the year nine months ended September 30, 2024, cash used in financing activities was $24,163,604, consisting of cash paid for the redemption of Public Units of $25,747,589 and the repayment of borrowing from related parties of $80,000, that were partially offset by cash proceeds from the target company of $1,476,882 and cash proceeds from the related party borrowing of $187,103.

For the year nine months ended September 30, 2023, cash used in financing activities was $45,887,982, consisting of cash paid for the redemption of Public Units of $46,169,982, that was partially offset by cash proceeds from the related party borrowing of $282,000.

As of September 30, 2024, the Company had cash held in the trust account of $1,109,108. We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account to complete our Initial Business Combination. We may withdraw interest to pay taxes. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Initial Business Combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of September 30, 2024, the Company had $378,755 of cash held outside of the trust account. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete an Initial Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with an Initial Business Combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an Initial Business Combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that an Initial Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment.

If our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an Initial Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Initial Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our Initial Business Combination, in which case we may issue additional securities or incur debt in connection with such Initial Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Initial Business Combination. If we are unable to complete our Initial Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition, following our Initial Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

Franchise and Income Tax Withdrawals from Trust Account

Since completion of its IPO on October 14, 2022, and through September 30, 2024, the Company withdrew $595,577 from the Trust Account to pay its liabilities related to the income and Delaware franchise taxes. Through September 30, 2023, the Company remitted $215,265 to the Delaware franchise tax authorities, which resulted in remaining excess of funds withdrawn from the Trust Account, but not remitted to the government authorities of $380,312. Additionally, as of September 30, 2024, the Company had accrued but unpaid income tax liability of $941,000, unpaid excise tax liability of $719,176 and unpaid liability for the Delaware franchise tax of $283,074. As of September 30, 2024, the Company had $378,755 in its operating account and inadvertently used all of the funds withdrawn from the Trust Account for payment of other operating expenses not related to taxes. Management determined that this use of funds was not in accordance with the Trust Agreement.

The Company continues to incur further tax liabilities and intends to cover such liabilities from the funds in its operating account and, if necessary, from the proceeds from the promissory note to Sponsor, without additional withdrawals from the Trust Account, until the excess of the funds withdrawn from the Trust Account over the amounts remitted to the government authorities is cured.

Nasdaq Compliance

Accordingly, the Staff has determined that the Company’s securities will be delisted from The Nasdaq Global Market. In that regard, unless the Company requests an appeal of this determination by July 30, 2024, trading of the Company’s ordinary shares, warrants, and units will be suspended at the opening of business on August 1, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market. However, the Company has appealed the Staff’s determination to the Hearings Panel.

In response to the Nasdaq delisting notice, on July 23, 2024, the Company applied to transfer from Nasdaq Global Market to Nasdaq Capital Market; on July 24, 2024, the Company requested and paid the $20,000 fee for the hearing; and as of the same date, the Company received hearing instructions from Nasdaq. The Company submitted its written submission to Nasdaq on August 2, 2024, and on August 12, 2024, the Company received a notification from Nasdaq that it has cured its filing discrepancies under Listing Rule 5250(c)(1). A Hearing on this matter was held on August 22, 2024, in which the Company presented its case to the Staff.

The Company is advised that January 20, 2025, represents the full extent of the Panel’s discretion to grant continued listing while the Company is non-compliant with Listing Rule IM-5101-2.

Going Concern

In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” we have until October 18, 2025, assuming the monthly extension requirements are satisfied, to consummate a Business Combination. Following the first extension, we are able to extend the date by which an Initial Business Combination must be consummated beyond July 18, 2023 up to nine times for an additional one month each time to April 18, 2024 upon the deposit into the Trust Account of $80,000 each calendar month. Following the second extension, we are able to extend the date by which an Initial Business Combination must be consummated beyond April 18, 2024 up to an additional nine times for an additional one month each time to January 18, 2025 upon the deposit into the Trust Account of $25,000 each calendar month, with monthly extension payments ceasing on July 5, 2024. Following the third extension, we are able to extend the date by which an Initial Business Combination must be consummated beyond January 18, 2025 up to nine times for an additional one month each time to October 18, 2025. It is uncertain that we will be able to consummate a Business Combination by this time. If a Business Combination is not consummated within the Combination Period, there will be a mandatory liquidation and subsequent dissolution. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about our ability to continue as a going concern. Management intends to complete a Business Combination prior to the end of the Combination Period. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after the end of the Combination Period.

Off-Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of September 30, 2024.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the sponsor a monthly fee of $20,000 for office space, utilities and secretarial and administrative support provided to the Company. We began incurring these fees on October 18, 2022 and will continue to incur these fees monthly until the earlier of the consummation of an Initial Business Combination or our liquidation.

As of September 30, 2024, we had recorded deferred underwriting commissions of $2,723,060 payable only upon completion of our Initial Business Combination, which consisted of deferred underwriting commissions and representative shares (see Note 5).

Critical Accounting Estimates

The preparation of the financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.

The Company’s significant accounting estimates include, but are not limited to, the valuation allowance for deferred tax assets and estimates and assumptions that affect the fair value of representative shares and unit purchase option.

Cybersecurity

Risk Management and Strategy

We recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data.

Managing Material Risks & Integrated Overall Risk Management

We have strategically integrated cybersecurity risk management into our broader risk management framework to promote a company-wide culture of cybersecurity risk management. This integration ensures that cybersecurity considerations are an integral part of our decision-making processes at every level. Our management team continuously evaluates and addresses cybersecurity risks in alignment with our business objectives and operational needs.

Oversee Third-party Risk

Because we are aware of the risks associated with third-party service providers, we have implemented stringent processes to oversee and manage these risks. We conduct thorough security assessments of all third-party providers before engagement and maintain ongoing monitoring to ensure compliance with our cybersecurity standards. The monitoring includes annual assessments of the SOC reports of our providers and implementing complementary controls. This approach is designed to mitigate risks related to data breaches or other security incidents originating from third-parties.

Risks from Cybersecurity Threats

We have not encountered cybersecurity challenges that have materially impaired our operations or financial standing.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures means controls and procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving their desired control objectives.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our management carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures under the supervision of our Chief Executive Officer and our Chief Financial Officer and concluded that our disclosure controls and procedures were not effective as of September 30, 2024 because the material weaknesses in our internal control over financial reporting as of December 31, 2022 and as described below, continues to exist as of September 30, 2024.

In connection with management’s report on internal controls over financial reporting included in our Annual Report on Form 10-K for the year ended December 31, 2022, management concluded that, as of December 31, 2022, our internal control over financial reporting was not effective as of December 31, 2022. We identified material weaknesses in our internal control over financial reporting, and those material weaknesses were not fully remediated as of September 30, 2024. The following material weaknesses continue to exist in our internal control over financial reporting:

delinquent filings with the SEC including Form 10-K for the year ended December 31, 2022, Form 10-Q for the period ended March 31, 2023, and Form 10-Q for the period ended June 30, 2023;

complex accounting, specifically the accounting for representative shares and the Unit Purchase Option; and

the timely forfeiture of founder shares upon the over-allotment in connection with the Initial Public Offering.

A material weakness, as defined in the SEC regulations, is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles.

Management plans to remediate the material weakness by enhancing our processes to identify and appropriately apply applicable accounting requirements and increased communication among our personnel and third-party professionals with whom we consult regarding accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

Changes in Internal Control over Financial Reporting

Other than the remediation efforts described above, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

Factors that could cause our actual results to differ materially from those in this Quarterly Report include the risk factors described in our Annual Report on Form 10-K filed with the SEC. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

For a description of the use of the proceeds generated in our Public Offering, see Part I, Item 2 of this Form 10-Q.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.		Description of Exhibit
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	HUDSON ACQUISITION I CORP.

Date: November 14, 2024	By:	/s/ Warren Wang
		Warren Wang
		Chief Executive Officer (Principal Executive Officer)

Date: November 14, 2024	By:	/s/ Pengfei Xie
		Pengfei Xie
		Chief Financial Officer (Principal Financial and Accounting Officer)

86-2712843 P5Y P7Y false --12-31 Q3 0001853047 0001853047 2024-01-01 2024-09-30 0001853047 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001853047 huda:RightMember 2024-01-01 2024-09-30 0001853047 huda:UnitsMember 2024-01-01 2024-09-30 0001853047 2024-11-12 0001853047 2024-09-30 0001853047 2023-12-31 0001853047 us-gaap:RelatedPartyMember 2024-09-30 0001853047 us-gaap:RelatedPartyMember 2023-12-31 0001853047 2024-07-01 2024-09-30 0001853047 2023-07-01 2023-09-30 0001853047 2023-01-01 2023-09-30 0001853047 huda:CommonStockSubjectToPossibleRedemptionMember 2024-07-01 2024-09-30 0001853047 huda:CommonStockSubjectToPossibleRedemptionMember 2023-07-01 2023-09-30 0001853047 huda:CommonStockSubjectToPossibleRedemptionMember 2024-01-01 2024-09-30 0001853047 huda:CommonStockSubjectToPossibleRedemptionMember 2023-01-01 2023-09-30 0001853047 huda:NonredeemableCommonSharesMember 2024-07-01 2024-09-30 0001853047 huda:NonredeemableCommonSharesMember 2023-07-01 2023-09-30 0001853047 huda:NonredeemableCommonSharesMember 2024-01-01 2024-09-30 0001853047 huda:NonredeemableCommonSharesMember 2023-01-01 2023-09-30 0001853047 us-gaap:CommonStockMember 2024-06-30 0001853047 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001853047 us-gaap:RetainedEarningsMember 2024-06-30 0001853047 2024-06-30 0001853047 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001853047 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001853047 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001853047 us-gaap:CommonStockMember 2024-09-30 0001853047 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001853047 us-gaap:RetainedEarningsMember 2024-09-30 0001853047 us-gaap:CommonStockMember 2023-06-30 0001853047 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001853047 us-gaap:RetainedEarningsMember 2023-06-30 0001853047 2023-06-30 0001853047 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001853047 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001853047 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001853047 us-gaap:CommonStockMember 2023-09-30 0001853047 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001853047 us-gaap:RetainedEarningsMember 2023-09-30 0001853047 2023-09-30 0001853047 us-gaap:CommonStockMember 2023-12-31 0001853047 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001853047 us-gaap:RetainedEarningsMember 2023-12-31 0001853047 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001853047 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001853047 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001853047 us-gaap:CommonStockMember 2022-12-31 0001853047 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001853047 us-gaap:RetainedEarningsMember 2022-12-31 0001853047 2022-12-31 0001853047 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001853047 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001853047 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001853047 huda:HudsonAcquisitionICorpMember 2024-01-01 2024-09-30 0001853047 us-gaap:CommonStockMember us-gaap:IPOMember 2022-10-18 2022-10-18 0001853047 us-gaap:IPOMember 2022-10-18 0001853047 us-gaap:IPOMember 2022-10-18 2022-10-18 0001853047 us-gaap:PrivatePlacementMember 2024-01-01 2024-09-30 0001853047 us-gaap:PrivatePlacementMember 2024-09-30 0001853047 us-gaap:OverAllotmentOptionMember 2022-10-21 2022-10-21 0001853047 2022-10-21 0001853047 us-gaap:OverAllotmentOptionMember 2024-01-01 2024-09-30 0001853047 us-gaap:OverAllotmentOptionMember 2022-10-21 0001853047 us-gaap:IPOMember 2024-01-01 2024-09-30 0001853047 huda:SponsorMember 2024-01-01 2024-09-30 0001853047 huda:SpecialMeetingMember us-gaap:CommonStockMember 2023-06-28 0001853047 huda:VotingSharesMember us-gaap:CommonStockMember 2023-06-28 0001853047 2023-06-28 2023-06-28 0001853047 2024-04-18 0001853047 2023-07-25 0001853047 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-09-30 0001853047 huda:HudsonAcquisitionICorpMember 2024-04-17 0001853047 huda:HudsonAcquisitionICorpMember 2024-04-17 2024-04-17 0001853047 huda:HudsonAcquisitionICorpMember huda:ExtensionAmendmentMember 2024-04-17 0001853047 2024-06-04 0001853047 2024-06-04 2024-06-04 0001853047 huda:ExtensionAmendmentMember 2024-09-30 0001853047 huda:HudsonAcquisitionICorpMember 2024-09-30 0001853047 2024-07-24 2024-07-24 0001853047 huda:UnitPurchaseOptionMember huda:UnderwriterMember 2024-01-01 2024-09-30 0001853047 huda:UnitPurchaseOptionMember us-gaap:OverAllotmentOptionMember 2024-01-01 2024-09-30 0001853047 huda:UnitPurchaseOptionMember us-gaap:OverAllotmentOptionMember 2022-10-21 2022-10-21 0001853047 huda:UnitPurchaseOptionMember huda:UnderwriterMember 2024-09-30 0001853047 huda:UnitPurchaseOptionMember 2024-01-01 2024-09-30 0001853047 huda:UnitPurchaseOptionMember us-gaap:IPOMember 2024-09-30 0001853047 srt:MinimumMember 2024-01-01 2024-09-30 0001853047 srt:MaximumMember 2024-01-01 2024-09-30 0001853047 us-gaap:CommonStockMember 2022-12-31 0001853047 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001853047 us-gaap:CommonStockMember 2023-12-31 0001853047 us-gaap:CommonStockMember 2024-09-30 0001853047 huda:NonRedeemableCommonStockMember 2024-07-01 2024-09-30 0001853047 huda:NonRedeemableCommonStockMember 2023-07-01 2023-09-30 0001853047 huda:NonRedeemableCommonStockMember 2024-01-01 2024-09-30 0001853047 huda:NonRedeemableCommonStockMember 2023-01-01 2023-09-30 0001853047 huda:SponsorMember us-gaap:IPOMember 2024-09-30 0001853047 us-gaap:PrivatePlacementMember 2022-10-18 2022-10-18 0001853047 us-gaap:PrivatePlacementMember 2022-10-18 0001853047 us-gaap:PrivatePlacementMember 2022-11-30 0001853047 us-gaap:PrivatePlacementMember 2022-12-01 0001853047 huda:UnderwritingAgreementMember us-gaap:OverAllotmentOptionMember 2022-10-21 2022-10-21 0001853047 us-gaap:PrivatePlacementMember 2022-10-21 2022-10-21 0001853047 2022-10-14 0001853047 huda:SponsorMember us-gaap:PrivatePlacementMember 2024-09-30 0001853047 2022-10-21 2022-10-21 0001853047 us-gaap:OverAllotmentOptionMember 2022-10-14 0001853047 us-gaap:OverAllotmentOptionMember 2022-10-14 2022-10-14 0001853047 huda:PromissoryNoteMember 2021-04-28 0001853047 huda:PromissoryNoteMember 2022-09-08 0001853047 srt:MaximumMember huda:SponsorMember 2024-09-30 0001853047 huda:PromissoryNoteMember huda:SponsorMember 2024-09-30 0001853047 2021-05-06 0001853047 2022-04-15 0001853047 2022-08-19 0001853047 huda:SponsorMember 2022-12-01 0001853047 huda:PromissoryNoteMember 2023-07-20 0001853047 huda:PromissoryNoteMember us-gaap:PrivatePlacementMember 2023-07-20 0001853047 huda:PromissoryNoteMember 2024-01-01 2024-09-30 0001853047 huda:PromissoryNoteMember 2023-01-01 2023-12-31 0001853047 huda:UnsecuredPromissoryNoteMember 2023-07-18 0001853047 2023-07-24 0001853047 huda:SponsorMember 2024-04-18 0001853047 huda:UnsecuredPromissoryNoteMember 2024-01-01 2024-09-30 0001853047 huda:UnsecuredPromissoryNoteMember 2023-01-01 2023-12-31 0001853047 huda:AdministrativeSupportAgreementMember 2022-10-14 2022-10-14 0001853047 huda:AdministrativeSupportAgreementMember 2024-07-01 2024-09-30 0001853047 huda:AdministrativeSupportAgreementMember 2023-07-01 2023-09-30 0001853047 huda:AdministrativeSupportAgreementMember 2024-01-01 2024-09-30 0001853047 huda:AdministrativeSupportAgreementMember 2023-01-01 2023-09-30 0001853047 2024-03-31 0001853047 2024-11-01 2024-11-01 0001853047 huda:UnitPurchaseOptionMember huda:UnderwriterMember 2024-01-01 2024-09-30 0001853047 huda:UnitPurchaseOptionMember huda:UnderwriterMember us-gaap:OverAllotmentOptionMember 2024-01-01 2024-09-30 0001853047 huda:UnitPurchaseOptionMember huda:UnderwriterMember us-gaap:OverAllotmentOptionMember 2022-10-21 2022-10-21 0001853047 huda:UnitPurchaseOptionMember huda:UnderwriterMember 2022-10-21 2022-10-21 0001853047 us-gaap:IPOMember 2024-09-30 0001853047 2024-05-14 2024-05-14 0001853047 huda:AiwaysAutomobileEuropeGmbHMember 2024-05-14 0001853047 2024-08-31 2024-08-31 0001853047 huda:AiwaysAutomobileEuropeGmbHMember 2024-08-31 0001853047 2024-09-25 2024-09-25 0001853047 huda:PromissoryNoteMember 2024-09-25 0001853047 huda:FounderSharesMember 2021-01-13 2021-01-13 0001853047 huda:FounderSharesMember 2021-05-11 2021-05-11 0001853047 huda:FounderSharesMember 2024-01-01 2024-09-30 0001853047 huda:FounderSharesMember 2021-12-10 2021-12-10 0001853047 us-gaap:IPOMember 2022-10-21 2022-10-21 0001853047 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001853047 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001853047 huda:PromissoryNoteMember us-gaap:SubsequentEventMember 2024-10-03 2024-10-03 0001853047 us-gaap:SubsequentEventMember 2024-10-03 2024-10-03 0001853047 us-gaap:SubsequentEventMember 2024-10-29 2024-10-29 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULES 13a-14(a) OR 15D-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Warren Wang, certify that:

I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2024, of Hudson Acquisition I Corp.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

November 14, 2024

/s/ Warren Wang
Warren Wang
Chief Executive Officer
(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULES 13a-14(a) OR 15D-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Pengfei Xie, certify that:

I have reviewed this Quarterly Report on Form 10-Q for the period ended September 30, 2024, of Hudson Acquisition I Corp.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

November 14, 2024

/s/ Pengfei Xie
Pengfei Xie
Chief Financial Officer
(Principal Financial and Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hudson Acquisition I Corp. (the “Company”) on Form 10-Q, for the period ended September 30, 2024, as filed with the Securities and Exchange Commission, I, Warren Wang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Quarterly Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

November 14, 2024

/s/ Warren Wang
Warren Wang
Chief Executive Officer
(Principal Executive Officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hudson Acquisition I Corp. (the “Company”) on Form 10-Q, for the period ended September 30, 2024, as filed with the Securities and Exchange Commission, I, Pengfei Xie, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Quarterly Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

November 14, 2024

/s/ Pengfei Xie
Pengfei Xie
Chief Financial Officer
(Principal Financial and Accounting Officer)

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2024	Nov. 12, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Information [Line Items]
Entity Registrant Name	HUDSON ACQUISITION I CORP.
Entity Central Index Key	0001853047
Entity File Number	001-41532
Entity Tax Identification Number	86-2712843
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	19 West 44th Street,
Entity Address, Address Line Two	Suite 1001
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10036
Entity Phone Fax Numbers [Line Items]
City Area Code	(347)
Local Phone Number	410-4710
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		2,181,088
Common Stock
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock
Trading Symbol	HUDA
Security Exchange Name	NASDAQ
Rights
Entity Listings [Line Items]
Title of 12(b) Security	Rights
Trading Symbol	HUDAR
Security Exchange Name	NASDAQ
Units
Entity Listings [Line Items]
Title of 12(b) Security	Units
Trading Symbol	HUDAU
Security Exchange Name	NASDAQ

Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash	$ 378,755	$ 11,700
Prepaid expenses and other current assets	55,000	11,748
Total current assets	433,755	23,448
Marketable securities held in Trust Account	1,109,108	26,036,953
Interest receivable on cash and marketable securities held in the Trust Account	4,586
Total assets	1,547,449	26,060,401
Current liabilities:
Accounts payable and accrued liabilities	455,944	601,469
Advance from target company for de-SPAC transaction	1,477,765
Franchise tax payable	283,074	68,308
Income tax payable	941,000	764,000
Excise tax payable	719,176	461,700
Total current liabilities	4,627,770	2,539,185
Deferred underwriting commissions	2,723,060	2,723,060
Total liabilities	7,350,830	5,262,245
Commitments and Contingencies (Note 5)
Common stock subject to possible redemption, 98,263 and 2,417,331 shares at redemption value of $9.10 and $10.56 per share as of September 30, 2024 and December 31, 2023, respectively	893,766	25,526,944
Stockholders’ deficit:
Common stock, par value $0.0001, 200,000,000 shares authorized; 2,082,825 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	209	209
Additional paid-in capital
Accumulated deficit	(6,697,356)	(4,728,997)
Total stockholders’ deficit	(6,697,147)	(4,728,788)
Total liabilities, redeemable common stock and stockholders’ deficit	1,547,449	26,060,401
Related Party
Current liabilities:
Notes payable - related party	$ 750,811	$ 643,708

Condensed Balance Sheets (Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock subject to possible redemption, shares	98,263	2,417,331
Common stock subject to possible redemption, redemption value per share (in Dollars per share)	$ 9.1	$ 10.56
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	2,082,825	2,082,825
Common stock, shares outstanding	2,082,825	2,082,825

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
Statements of Operations (Unaudited) - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
General and administrative expenses	$ 306,524	$ 678,504	$ 776,033	$ 1,237,240
Franchise tax expense	18,600	50,000	42,600	150,000
Loss from operations	(325,124)	(728,504)	(818,633)	(1,387,240)
Other income (expense):
Interest earned on marketable securities held in Trust Account	19,751	393,358	569,338	1,940,473
Interest earned on cash account	699		1,990
Loss on overpayment of franchise tax	(172,166)		(172,166)
Other income (expense), net	(151,716)	393,358	399,162	1,940,473
Income (loss) before income taxes	(476,840)	(335,146)	(419,471)	553,233
Provision for income taxes	(11,355)	(108,000)	(434,476)	(563,000)
Net loss	(488,195)	(443,146)	(853,947)	(9,767)
Common Stock Subject to Possible Redemption
Other income (expense):
Net income attributable to common stock subject to possible redemption	$ 8,396	$ 285,358	$ 134,862	$ 1,377,473
Weighted-average common shares outstanding, Basic (in Shares)	99,098	3,204,525	1,005,041	5,631,708
Weighted-average common shares outstanding, Diluted (in Shares)	99,098	3,204,525	1,005,041	5,631,708
Basic net income per share (in Dollars per share)	$ 0.08	$ 0.09	$ 0.13	$ 0.24
Diluted net income per share (in Dollars per share)	$ 0.08	$ 0.09	$ 0.13	$ 0.24
Non-Redeemable Common Stock
Other income (expense):
Net income attributable to common stock subject to possible redemption	$ (496,591)	$ (728,504)	$ (988,809)	$ (1,387,240)
Weighted-average common shares outstanding, Basic (in Shares)	2,082,825	2,082,825	2,082,825	2,082,825
Weighted-average common shares outstanding, Diluted (in Shares)	2,082,825	2,082,825	2,082,825	2,082,825
Basic net income per share (in Dollars per share)	$ (0.24)	$ (0.35)	$ (0.47)	$ (0.67)
Diluted net income per share (in Dollars per share)	$ (0.24)	$ (0.35)	$ (0.47)	$ (0.67)

Statements of Stockholders’ Deficit (Unaudited) - USD ($)	Common Stock	Accumulated Deficit	Total
Balance at Dec. 31, 2022	$ 209	$ (2,477,925)	$ (2,477,716)
Balance (in Shares) at Dec. 31, 2022	2,082,825
Accretion of carrying value to redemption value		(1,467,472)	(1,467,472)
Excise tax payable attributable to redemption of common stock		(461,700)	(461,700)
Net loss		(9,767)	(9,767)
Balance at Sep. 30, 2023	$ 209	(4,416,864)	(4,416,655)
Balance (in Shares) at Sep. 30, 2023	2,082,825
Balance at Jun. 30, 2023	$ 209	(3,036,661)	(3,036,452)
Balance (in Shares) at Jun. 30, 2023	2,082,825
Accretion of carrying value to redemption value		(475,357)	(475,357)
Excise tax payable attributable to redemption of common stock		(461,700)	(461,700)
Net loss		(443,146)	(443,146)
Balance at Sep. 30, 2023	$ 209	(4,416,864)	(4,416,655)
Balance (in Shares) at Sep. 30, 2023	2,082,825
Balance at Dec. 31, 2023	$ 209	(4,728,997)	$ (4,728,788)
Balance (in Shares) at Dec. 31, 2023	2,082,825		2,082,825
Accretion of carrying value to redemption value		(856,936)	$ (856,936)
Excise tax payable attributable to redemption of common stock		(257,476)	(257,476)
Net loss		(853,947)	(853,947)
Balance at Sep. 30, 2024	$ 209	(6,697,356)	$ (6,697,147)
Balance (in Shares) at Sep. 30, 2024	2,082,825		2,082,825
Balance at Jun. 30, 2024	$ 209	(6,261,751)	$ (6,261,542)
Balance (in Shares) at Jun. 30, 2024	2,082,825
Accretion of carrying value to redemption value		52,944	52,944
Excise tax payable attributable to redemption of common stock		(355)	(355)
Net loss		(488,195)	(488,195)
Balance at Sep. 30, 2024	$ 209	$ (6,697,356)	$ (6,697,147)
Balance (in Shares) at Sep. 30, 2024	2,082,825		2,082,825

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2024	Sep. 30, 2023
OPERATING ACTIVITIES
Net loss	$ (853,947)	$ (9,767)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(569,338)	(1,940,473)
Amortization on debt discount on note payable to target company	883
Change in operating assets and liabilities:
Prepaid expenses and other current assets	(43,252)	94,353
Accounts payable and accrued expenses	(145,526)	673,939
Franchise tax payable	214,766	(65,315)
Income tax payable	177,000	563,000
Excise tax payable	257,476
Related party payables		74,063
Net cash used in operating activities	(961,938)	(610,200)
INVESTING ACTIVITIES
Investment of cash in Trust Account	(552,954)	(80,000)
Cash withdrawn from Trust Account	26,045,551	46,467,597
Net cash provided by investing activities	25,492,597	46,387,597
FINANCING ACTIVITIES
Redemption of common stock	(25,747,589)	(46,169,982)
Proceeds from advances from target company	1,476,882
Proceeds of notes payable - related party	187,103	282,000
Repayment of borrowing from related parties	(80,000)
Net cash used in financing activities	(24,163,604)	(45,887,982)
Net increase in cash during period	367,055	(110,585)
Cash, beginning of period	11,700	138,917
Cash, end of period	378,755	28,332
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES
Change in value of common stock subject to possible redemption	24,633,178	44,702,509
Debt discount on note payable to related party	$ 23,118

Nature of the Organization and Business

9 Months Ended

Sep. 30, 2024

Nature of the Organization and Business [Abstract]

NATURE OF THE ORGANIZATION AND BUSINESS

NOTE 1 — NATURE OF THE ORGANIZATION AND BUSINESS

Throughout this report, the terms “our,” “we,” “us,” and the “Company” refer to Hudson Acquisition I Corp.

Extension Amendment

Liquidity and Capital Resources

Nasdaq Compliance

In response to the Nasdaq delisting notice, the Company has taken the following actions:

●

On July 23, 2024, the Company applied to transfer from Nasdaq Global Market to Nasdaq Capital Market.

●

On July 24, 2024, the Company requested a hearing and paid the $20,000 fee for the hearing.

●

On July 24, 2024, the Company received hearing instructions from Nasdaq, and has secured the hearing date for August 22, 2024.

The Company submitted its written submission to Nasdaq on August 2, 2024.

The Company filed its Form 10-K for the year ended December 31, 2023 on July 23, 2024. The Company filed its Form 10-Q for the three months ended March 31, 2024 on August 2, 2024.

On August 12, 2024, the Company received a notification from Nasdaq that it has cured its filing discrepancies under Listing Rule 5250(c)(1).

The Company has come up with a series of action plans to regain compliance, and presented its case to Nasdaq Panel on its hearing on August 22, 2024.

The Company is advised that January 20, 2025, represents the full extent of the Panel’s discretion to grant continued listing while the Company is non-compliant with Listing Rule IM-5101-2.

Basis of Presentation and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2024

Basis of Presentation and Summary of Significant Accounting Policies [Abstract]

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 — BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Emerging Growth Company

Use of Estimates

Cash and Cash Equivalents

Marketable Securities Held in Trust Account

Offering Costs

Offering costs consist of professional fees, filing, regulatory and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering.

Common Stock Subject to Possible Redemption

As of September 30, 2024 and December 31, 2023, the common stock subject to possible redemption reflected on the condensed balance sheet is reflected in the following table:

Common stock subject to possible redemption, December 31, 2022	$	69,786,334
Less:
Redemption of common stock in connection with Trust Extension		(46,169,982	)
Add:
Accretion of carrying value to redemption value		1,910,592
Common stock subject to possible redemption, December 31, 2023	$	25,526,944
Less:
Redemption of common stock		(25,747,589	)
Add:
Accretion of carrying value to redemption value		1,114,411
Common stock subject to possible redemption, September 30, 2024		893,766

Income Taxes

Net (Loss) Income per Share of Common Stock

	Three Months Ended September 30,						Nine Months Ended September 30,
	2024			2023			2024			2023
Common stock subject to possible redemption
Numerator: Earnings allocable to common stock subject to redemption
Interest earned on marketable securities held in Trust Account, net of taxes	$	8,396		$	285,358		$	134,862		$	1,377,473
Net income attributable to common stock subject to possible redemption	$	8,396		$	285,358		$	134,862		$	1,377,473
Denominator: Weighted average common shares subject to redemption
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption		99,098			3,204,525			1,005,041			5,631,708
Basic and diluted net income per share, common stock subject to possible redemption	$	0.08		$	0.09		$	0.13		$	0.24

Non-Redeemable common stock
Numerator: Net loss minus net earnings - Basic and diluted
Net loss	$	(488,195	)	$	(443,146	)	$	(853,947	)	$	(9,767	)
Less: net income attributable to common stock subject to redemption		(8,396	)		(285,358	)		(134,862	)		(1,377,473	)
Net loss attributable to non-redeemable common stock	$	(496,591	)	$	(728,504	)	$	(988,809	)	$	(1,387,240	)
Denominator: Weighted average non-redeemable common shares
Weighted-average non-redeemable common shares outstanding, basic and diluted		2,082,825			2,082,825			2,082,825			2,082,825
Basic and diluted net loss per share, non-redeemable common stock	$	(0.24	)	$	(0.35	)	$	(0.47	)	$	(0.67	)

Concentration of Credit Risk

Fair Value of Financial Instruments

Fair Value Measurements

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●

Unit Purchase Option

Representative Shares

Recent Accounting Pronouncements

Risks and Uncertainties

Initial Public Offering

9 Months Ended

Sep. 30, 2024

Initial Public Offering [Abstract]

INITIAL PUBLIC OFFERING

NOTE 3 — INITIAL PUBLIC OFFERING

Related Party Transactions

9 Months Ended

Sep. 30, 2024

RELATED PARTY TRANSACTIONS

NOTE 4 — RELATED PARTY TRANSACTIONS

Private Placement Units

Promissory Note — Related Party

On December 1, 2022, the Sponsor applied the outstanding balance on the Promissory Note of $500,000 towards the payments for Private Placement Units.

Administrative Support Agreement

Commitments and Contingencies

9 Months Ended

Sep. 30, 2024

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 5 — COMMITMENTS AND CONTINGENCIES

Registration Rights

Underwriting Agreement

Excise Tax

Unit Purchase Option

Agreement with Aiways Automobile Europe GmbH

As of September 30, 2024, the balance in the advance from target company for de-SPAC transaction account was $1,477,765.

Common Stock Subject to Possible Redemption

9 Months Ended

Sep. 30, 2024

Common Stock Subject to Possible Redemption [Abstract]

COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION

NOTE 6 — COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION

Stockholders’ Deficit

9 Months Ended

Sep. 30, 2024

Stockholders’ Deficit [Abstract]

STOCKHOLDERS’ DEFICIT

NOTE 7 — STOCKHOLDERS’ DEFICIT

Authorized Shares

Founder’s Shares

Initial Public Offering

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased a total of 340,000 Initial Private Placement Units at a price of $10.00 per Unit.

Rights

Fair Value Measurements

9 Months Ended

Sep. 30, 2024

Fair Value Measurements [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 8 — FAIR VALUE MEASUREMENTS

Description:	Level		September 30, 2024		December 31, 2023
Assets:
Cash and marketable securities held in Trust Account		1	$	1,109,108	$	26,036,953

Subsequent Events

9 Months Ended

Sep. 30, 2024

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 9 — SUBSEQUENT EVENTS

On October 3, 2024, the Company paid down the promissory notes to its Sponsor in the amount of $80,000. The balance of notes payable to related party was reduced to $670,811 subsequently.

Pay vs Performance Disclosure - USD ($)	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (488,195)	$ (443,146)	$ (853,947)	$ (9,767)

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy (Policies)

9 Months Ended

Sep. 30, 2024

Basis of Presentation and Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Emerging Growth Company

Emerging Growth Company

Use of Estimates

Use of Estimates

Cash and Cash Equivalents

Cash and Cash Equivalents

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

Offering Costs

Offering Costs

Offering costs consist of professional fees, filing, regulatory and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering.

Common Stock Subject to Possible Redemption

Common Stock Subject to Possible Redemption

As of September 30, 2024 and December 31, 2023, the common stock subject to possible redemption reflected on the condensed balance sheet is reflected in the following table:

Common stock subject to possible redemption, December 31, 2022	$	69,786,334
Less:
Redemption of common stock in connection with Trust Extension		(46,169,982	)
Add:
Accretion of carrying value to redemption value		1,910,592
Common stock subject to possible redemption, December 31, 2023	$	25,526,944
Less:
Redemption of common stock		(25,747,589	)
Add:
Accretion of carrying value to redemption value		1,114,411
Common stock subject to possible redemption, September 30, 2024		893,766

Income Taxes

Income Taxes

Net (Loss) Income per Share of Common Stock

Net (Loss) Income per Share of Common Stock

	Three Months Ended September 30,						Nine Months Ended September 30,
	2024			2023			2024			2023
Common stock subject to possible redemption
Numerator: Earnings allocable to common stock subject to redemption
Interest earned on marketable securities held in Trust Account, net of taxes	$	8,396		$	285,358		$	134,862		$	1,377,473
Net income attributable to common stock subject to possible redemption	$	8,396		$	285,358		$	134,862		$	1,377,473
Denominator: Weighted average common shares subject to redemption
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption		99,098			3,204,525			1,005,041			5,631,708
Basic and diluted net income per share, common stock subject to possible redemption	$	0.08		$	0.09		$	0.13		$	0.24

Non-Redeemable common stock
Numerator: Net loss minus net earnings - Basic and diluted
Net loss	$	(488,195	)	$	(443,146	)	$	(853,947	)	$	(9,767	)
Less: net income attributable to common stock subject to redemption		(8,396	)		(285,358	)		(134,862	)		(1,377,473	)
Net loss attributable to non-redeemable common stock	$	(496,591	)	$	(728,504	)	$	(988,809	)	$	(1,387,240	)
Denominator: Weighted average non-redeemable common shares
Weighted-average non-redeemable common shares outstanding, basic and diluted		2,082,825			2,082,825			2,082,825			2,082,825
Basic and diluted net loss per share, non-redeemable common stock	$	(0.24	)	$	(0.35	)	$	(0.47	)	$	(0.67	)

Concentration of Credit Risk

Concentration of Credit Risk

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair Value Measurements

Fair Value Measurements

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●

Unit Purchase Option

Unit Purchase Option

Representative shares

Representative Shares

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Risks and Uncertainties

Risks and Uncertainties

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2024

Basis of Presentation and Summary of Significant Accounting Policies [Abstract]

Schedule of Common Stock Subject to Possible Redemption

As of September 30, 2024 and December 31, 2023, the common stock subject to possible redemption reflected on the condensed balance sheet is reflected in the following table:

Common stock subject to possible redemption, December 31, 2022	$	69,786,334
Less:
Redemption of common stock in connection with Trust Extension		(46,169,982	)
Add:
Accretion of carrying value to redemption value		1,910,592
Common stock subject to possible redemption, December 31, 2023	$	25,526,944
Less:
Redemption of common stock		(25,747,589	)
Add:
Accretion of carrying value to redemption value		1,114,411
Common stock subject to possible redemption, September 30, 2024		893,766

Schedule of Basic and Diluted Net Loss Per Share

The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per share for each class of shares.

	Three Months Ended September 30,						Nine Months Ended September 30,
	2024			2023			2024			2023
Common stock subject to possible redemption
Numerator: Earnings allocable to common stock subject to redemption
Interest earned on marketable securities held in Trust Account, net of taxes	$	8,396		$	285,358		$	134,862		$	1,377,473
Net income attributable to common stock subject to possible redemption	$	8,396		$	285,358		$	134,862		$	1,377,473
Denominator: Weighted average common shares subject to redemption
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption		99,098			3,204,525			1,005,041			5,631,708
Basic and diluted net income per share, common stock subject to possible redemption	$	0.08		$	0.09		$	0.13		$	0.24

Non-Redeemable common stock
Numerator: Net loss minus net earnings - Basic and diluted
Net loss	$	(488,195	)	$	(443,146	)	$	(853,947	)	$	(9,767	)
Less: net income attributable to common stock subject to redemption		(8,396	)		(285,358	)		(134,862	)		(1,377,473	)
Net loss attributable to non-redeemable common stock	$	(496,591	)	$	(728,504	)	$	(988,809	)	$	(1,387,240	)
Denominator: Weighted average non-redeemable common shares
Weighted-average non-redeemable common shares outstanding, basic and diluted		2,082,825			2,082,825			2,082,825			2,082,825
Basic and diluted net loss per share, non-redeemable common stock	$	(0.24	)	$	(0.35	)	$	(0.47	)	$	(0.67	)

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2024

Fair Value Measurements [Abstract]

Schedule of Assets that are Measured at Fair Value on a Recurring Basis

Description:	Level		September 30, 2024		December 31, 2023
Assets:
Cash and marketable securities held in Trust Account		1	$	1,109,108	$	26,036,953

Nature of the Organization and Business (Details) - USD ($)								9 Months Ended
	Jul. 24, 2024	Jun. 04, 2024	Apr. 17, 2024	Jun. 28, 2023	Oct. 21, 2022	Oct. 18, 2022	Oct. 14, 2022	Sep. 30, 2024	Jun. 30, 2024	Apr. 18, 2024	Dec. 31, 2023	Sep. 30, 2023	Jul. 25, 2023	Jul. 24, 2023	Jun. 30, 2023	Dec. 31, 2022
Nature of the Organization and Business [Line Items]
Sale of units (in Shares)					845,300
Sale price (in Dollars per share)					$ 10
Common stock shares (in Shares)								1
Common stock par value (in Dollars per share)								$ 0.0001			$ 0.0001
Price per share (in Dollars per share)					$ 10		$ 10
Borrowings under promissory note								$ 750,811
Interest to pay distribution expenses								$ 100,000
Common stock, outstanding (in Shares)								2,082,825			2,082,825
Percentage of voting rights				84.00%
Deposits into account								$ 80,000		$ 80,000				$ 80,000
Redemption price (in Dollars per share)								$ 9.1			$ 10.56
Amount withdraw from trust account													$ 46,169,982
Public shares outstanding (in Shares)													2,417,331
Net tangible assets								$ 5,000,001
Aggregate redemption amount								$ 35,457
Common stock outstanding (in Shares)		1,816,463
Shares of common stock (in Shares)		2,184,288
Percentage of shares held by proxy		98.00%
Public shares (in Shares)								3,200
Public shares outstanding (in Shares)								98,263
Operating bank account								$ 378,755			$ 11,700
Working capital								2,250,765
Market value of shares								$ 50,000,000
Publicly held shares (in Shares)								1,100,000
Market value of publicly held shares								$ 15,000,000
Paid fee	$ 20,000
Common Stock [Member]
Nature of the Organization and Business [Line Items]
Common stock par value (in Dollars per share)								$ 0.0001
Common stock, outstanding (in Shares)								2,082,825	2,082,825		2,082,825	2,082,825			2,082,825	2,082,825
Common stock shares (in Shares)								4,427,969
Redemption price (in Dollars per share)								$ 10.43
Extension Amendment [Member]
Nature of the Organization and Business [Line Items]
Redemption price (in Dollars per share)								$ 11.08
Business Combination [Member]
Nature of the Organization and Business [Line Items]
Deposits into account								$ 80,000
Hudson Acquisition I Corp [Member]
Nature of the Organization and Business [Line Items]
Entity incorporation, date of incorporation								Jan. 13, 2021
Deposits into account			$ 25,000					$ 25,000
Common stock shares (in Shares)			2,315,868
Redemption price (in Dollars per share)			$ 11.1
Public shares outstanding (in Shares)			101,463
Common Stock [Member] \| Special Meeting [Member]
Nature of the Organization and Business [Line Items]
Common stock, outstanding (in Shares)				8,928,125
Common Stock [Member] \| Voting Shares [Member]
Nature of the Organization and Business [Line Items]
Common stock, outstanding (in Shares)				8,556,625
IPO [Member]
Nature of the Organization and Business [Line Items]
Sale of units (in Shares)						6,000,000
Sale price (in Dollars per share)						$ 10
Gross proceeds						$ 60,000,000		$ 69,479,795
Number of units issued (in Shares)								340,000
Shares of common stock (in Shares)								136,906
IPO [Member] \| Common Stock [Member]
Nature of the Organization and Business [Line Items]
Sale of units (in Shares)						6,000,000
Initial Private Placement [Member]
Nature of the Organization and Business [Line Items]
Number of units issued (in Shares)					31,500	238,500		340,000
Price per share (in Dollars per share)								$ 10
Gross proceeds						$ 2,385,000
Shares of common stock (in Shares)								340,000
Overallotment Private Placement Units [Member]
Nature of the Organization and Business [Line Items]
Sale of units (in Shares)					845,300
Sale price (in Dollars per share)					$ 10
Gross proceeds								$ 8,453,000
Number of units issued (in Shares)					31,500
Price per share (in Dollars per share)					$ 10		$ 10
Gross proceeds					$ 315,000		$ 315,000
Sponsor [Member]
Nature of the Organization and Business [Line Items]
Aggregate amount								$ 1,000,000
Extension Amendment [Member] \| Hudson Acquisition I Corp [Member]
Nature of the Organization and Business [Line Items]
Aggregate redemption amount			$ 25,712,132

Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)			9 Months Ended
	Jun. 04, 2024	Oct. 21, 2022	Sep. 30, 2024
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Redeemable shares of common stock outstanding (in Shares)			98,263
Federal depository insurance coverage			$ 250,000
Representative shares initial fair value			$ 327,205
Percentage of public offering			115.00%
Representative shares (in Shares)	2,184,288
Unit Purchase Option [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Percentage of public offering			115.00%
Minimum [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Option grants rights period			5 years
Maximum [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Option grants rights period			7 years
Underwriter [Member] \| Unit Purchase Option [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Price per share (in Dollars per share)			$ 11.5
Underwriter [Member] \| Unit Purchase Option [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Sold to underwriter			$ 100
Over-Allotment Option [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Purchase units (in Shares)		31,500
Over-Allotment Option [Member] \| Unit Purchase Option [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Purchase units (in Shares)		57,044	57,500
Representative shares initial fair value		$ 25,099
Initial Public Offering [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Purchase units (in Shares)			340,000
Representative shares initial fair value			$ 327,205
Price per share (in Dollars per share)			$ 11.5
Representative shares (in Shares)			136,906
Initial Public Offering [Member] \| Unit Purchase Option [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Cash			$ 100

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Common Stock Subject to Possible Redemption - Common Stock [Member] - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Schedule of Common Stock Subject to Possible Redemption [Line Items]
Common stock subject to possible redemption at beginning	$ 25,526,944	$ 69,786,334
Less:
Redemption of common stock in connection with Trust Extension		(46,169,982)
Add:
Accretion of carrying value to redemption value	1,114,411	1,910,592
Common stock subject to possible redemption at ending	893,766	$ 25,526,944
Less:
Redemption of common stock	$ (25,747,589)

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of Basic and Diluted Net Loss Per Share - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Common Stock Subject to Possible Redemption [Member]
Numerator: Earnings allocable to common stock subject to redemption
Interest earned on marketable securities held in Trust Account, net of taxes	$ 8,396	$ 285,358	$ 134,862	$ 1,377,473
Net income attributable to common stock subject to possible redemption	$ 8,396	$ 285,358	$ 134,862	$ 1,377,473
Denominator: Weighted average common shares subject to redemption
Basic weighted average shares outstanding, common stock subject to possible redemption (in Shares)	99,098	3,204,525	1,005,041	5,631,708
Diluted weighted average shares outstanding, common stock subject to possible redemption (in Shares)	99,098	3,204,525	1,005,041	5,631,708
Basic net income per share, common stock subject to possible redemption (in Dollars per share)	$ 0.08	$ 0.09	$ 0.13	$ 0.24
Diluted net income per share, common stock subject to possible redemption (in Dollars per share)	$ 0.08	$ 0.09	$ 0.13	$ 0.24
Numerator: Net loss minus net earnings - Basic and diluted
Net loss attributable to non-redeemable common stock	$ 8,396	$ 285,358	$ 134,862	$ 1,377,473
Non-Redeemable Common Stock [Member]
Denominator: Weighted average common shares subject to redemption
Basic weighted average shares outstanding, common stock subject to possible redemption (in Shares)	2,082,825	2,082,825	2,082,825	2,082,825
Diluted weighted average shares outstanding, common stock subject to possible redemption (in Shares)	2,082,825	2,082,825	2,082,825	2,082,825
Basic net income per share, common stock subject to possible redemption (in Dollars per share)	$ (0.24)	$ (0.35)	$ (0.47)	$ (0.67)
Diluted net income per share, common stock subject to possible redemption (in Dollars per share)	$ (0.24)	$ (0.35)	$ (0.47)	$ (0.67)
Numerator: Net loss minus net earnings - Basic and diluted
Net loss	$ (488,195)	$ (443,146)	$ (853,947)	$ (9,767)
Less: net income attributable to common stock subject to redemption	(8,396)	(285,358)	(134,862)	(1,377,473)
Net loss attributable to non-redeemable common stock	$ (496,591)	$ (728,504)	$ (988,809)	$ (1,387,240)

Initial Public Offering (Details) - USD ($)				9 Months Ended
Initial Public Offering (Details) - USD ($)	Oct. 21, 2022	Oct. 18, 2022	Oct. 14, 2022	Sep. 30, 2024	Dec. 31, 2023	Dec. 01, 2022	Nov. 30, 2022
Initial Public Offering [Line Items]
Sale of stock units (in Shares)	845,300
Price per share (in Dollars per share)	$ 10
Number of shares in a unit (in Shares)				1
Common stock, par value (in Dollars per share)				$ 0.0001	$ 0.0001
Price per share (in Dollars per share)	$ 10		$ 10
Common Stock [Member]
Initial Public Offering [Line Items]
Common stock, par value (in Dollars per share)				$ 0.0001
IPO [Member]
Initial Public Offering [Line Items]
Sale of stock units (in Shares)		6,000,000
Price per share (in Dollars per share)		$ 10
Gross proceeds		$ 60,000,000		$ 69,479,795
Number of units issued (in Shares)				340,000
IPO [Member] \| Sponsor [Member]
Initial Public Offering [Line Items]
Price per share (in Dollars per share)				$ 10
IPO [Member] \| Common Stock [Member]
Initial Public Offering [Line Items]
Sale of stock units (in Shares)		6,000,000
Private Placement [Member]
Initial Public Offering [Line Items]
Number of units issued (in Shares)	31,500	238,500		340,000
Price per share (in Dollars per share)				$ 10
Gross proceeds		$ 2,385,000
Trust account		$ 3,400,000
Additional received amount							$ 515,000
Reducing the balance amount							$ 500,000
Outstanding balance						$ 500,000
Private Placement [Member] \| Sponsor [Member]
Initial Public Offering [Line Items]
Price per share (in Dollars per share)				$ 10
Over-Allotment Option [Member]
Initial Public Offering [Line Items]
Sale of stock units (in Shares)	845,300
Price per share (in Dollars per share)	$ 10
Gross proceeds				$ 8,453,000
Number of units issued (in Shares)	31,500
Price per share (in Dollars per share)	$ 10		$ 10
Gross proceeds	$ 315,000		$ 315,000
Over-Allotment Option [Member] \| Underwriting Agreement [Member]
Initial Public Offering [Line Items]
Sale of stock units (in Shares)	845,300

Related Party Transactions (Details) - USD ($)					3 Months Ended		9 Months Ended		12 Months Ended
Related Party Transactions (Details) - USD ($)	Jun. 04, 2024	Oct. 21, 2022	Oct. 18, 2022	Oct. 14, 2022	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Apr. 18, 2024	Jul. 24, 2023	Jul. 20, 2023	Jul. 18, 2023	Dec. 01, 2022	Sep. 08, 2022	Aug. 19, 2022	Apr. 15, 2022	May 06, 2021	Apr. 28, 2021
Related Party Transactions [Line Items]
Sale of stock (in Shares)	2,184,288
Price per share (in Dollars per share)		$ 10		$ 10
Public offering sale of units (in Shares)		845,300
Share price (in Dollars per share)		$ 10
Common stock par value (in Dollars per share)					$ 0.0001		$ 0.0001		$ 0.0001
Promissory note drawdown amount																$ 100,000	$ 100,000	$ 300,000
Aggregate deposit amount					$ 80,000		$ 80,000			$ 80,000	$ 80,000
Investment of cash in trust account							552,954	$ 80,000
Promissory Note [Member]
Related Party Transactions [Line Items]
Principal amount												$ 1,000,000			$ 1,000,000				$ 1,000,000
Outstanding promissory note							750,811		$ 643,708
Investment of cash in trust account							80,000
Unsecured Promissory Note [Member]
Related Party Transactions [Line Items]
Principal amount													$ 720,000
Outstanding promissory note							$ 240,000		$ 240,000
Common Stock [Member]
Related Party Transactions [Line Items]
Common stock par value (in Dollars per share)					$ 0.0001		$ 0.0001
Sponsor [Member]
Related Party Transactions [Line Items]
Outstanding amount														$ 500,000
Aggregate deposit amount										$ 720,000
Sponsor [Member] \| Maximum [Member]
Related Party Transactions [Line Items]
Convertible debt					$ 1,000,000		$ 1,000,000
Administrative Support Agreement [Member]
Related Party Transactions [Line Items]
Administrative fees expense				$ 20,000	$ 60,000	$ 60,000	$ 180,000	$ 180,000
Private Placement [Member]
Related Party Transactions [Line Items]
Sale of stock (in Shares)							340,000
Price per share (in Dollars per share)					$ 10		$ 10
Number of units issued (in Shares)		31,500	238,500				340,000
Private placement			$ 2,385,000
Outstanding amount														$ 500,000
Private Placement [Member] \| Promissory Note [Member]
Related Party Transactions [Line Items]
Principal amount												$ 1,000,000
Conversion price per unit (in Dollars per share)												$ 10
Private Placement [Member] \| Sponsor [Member]
Related Party Transactions [Line Items]
Price per share (in Dollars per share)					10		$ 10
Over-Allotment Option [Member]
Related Party Transactions [Line Items]
Price per share (in Dollars per share)		$ 10		$ 10
Public offering sale of units (in Shares)		845,300
Share price (in Dollars per share)		$ 10
Gross proceeds							$ 8,453,000
Number of units issued (in Shares)		31,500
Private placement		$ 315,000		$ 315,000
Sponsor [Member] \| Promissory Note [Member]
Related Party Transactions [Line Items]
Conversion price per unit (in Dollars per share)					$ 10		$ 10

Commitments and Contingencies (Details) - USD ($)							3 Months Ended	9 Months Ended
Commitments and Contingencies (Details) - USD ($)	Nov. 01, 2024	Sep. 25, 2024	Aug. 31, 2024	Jun. 04, 2024	May 14, 2024	Oct. 21, 2022	Sep. 30, 2024	Sep. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Commitments and Contingencies [Line Items]
Underwriting discount per unit (in Dollars per share)								$ 0.2
Cash underwriting discount								$ 1,369,060
Offering expenses								100,000
Deferred underwriting commissions							$ 2,723,060	2,723,060	$ 2,723,060	$ 2,723,060
Representative shares (in Shares)				2,184,288
Representative shares initial fair value								$ 327,205
Percentage of exercise tax							1.00%	1.00%			1.00%
Excise tax liability							$ 719,176	$ 719,176		$ 461,700
Additional interest percentage	10.00%
Underpayment penalty percentage	5.00%
Unpaid liability percentage	25.00%
Sale of underwriter amount								$ 50,000,000
Percentage of public unit offering price								115.00%
Payment for cash								$ 100
Promissory note issued amount			$ 500,000		$ 1,000,000
Payment made to company					$ 1,000,000
Cash proceeds		$ 476,882
Principal amount							500,000	500,000
Amortization expense							$ 883	883
Advance amount								$ 1,477,765
Unit Purchase Option [Member]
Commitments and Contingencies [Line Items]
Percentage of public unit offering price								115.00%
Unit Purchase Option [Member] \| Underwriter [Member]
Commitments and Contingencies [Line Items]
Representative shares initial fair value						$ 25,099
Sale of underwriter amount								$ 100
Aiways Automobile Europe GmbH [Member]
Commitments and Contingencies [Line Items]
Fixed conversion price (in Dollars per share)			$ 10		$ 10
Promissory Note [Member]
Commitments and Contingencies [Line Items]
Principal amount		500,000
Original issuing discount		$ 23,118
IPO [Member]
Commitments and Contingencies [Line Items]
Representative shares (in Shares)								136,906
Representative shares initial fair value								$ 327,205
Number of units issued (in Shares)								340,000
Share price (in Dollars per share)							$ 11.5	$ 11.5
Over-Allotment Option [Member]
Commitments and Contingencies [Line Items]
Number of units issued (in Shares)						31,500
Over-Allotment Option [Member] \| Unit Purchase Option [Member]
Commitments and Contingencies [Line Items]
Representative shares initial fair value						$ 25,099
Number of units issued (in Shares)						57,044		57,500
Over-Allotment Option [Member] \| Unit Purchase Option [Member] \| Underwriter [Member]
Commitments and Contingencies [Line Items]
Number of units issued (in Shares)						57,044		57,500

Stockholders’ Deficit (Details) - USD ($)								9 Months Ended
Stockholders’ Deficit (Details) - USD ($)	Jun. 04, 2024	Oct. 21, 2022	Oct. 18, 2022	Oct. 14, 2022	Dec. 10, 2021	May 11, 2021	Jan. 13, 2021	Sep. 30, 2024	Dec. 31, 2023
Stockholders’ Deficit [Line Items]
Common stock, par value (in Dollars per share)								$ 0.0001	$ 0.0001
Common stock, authorized								200,000,000	200,000,000
Issuance of founder shares	2,184,288
Common stock shares outstanding								2,082,825	2,082,825
Share issued price per shares (in Dollars per share)		$ 10		$ 10
Founder Shares [Member]
Stockholders’ Deficit [Line Items]
Issuance of founder shares					1,725,000		2,875,000
Received common stock (in Dollars)						$ 25,000
Founder shares forfeited								375,000
Initial Public Offering [Member]
Stockholders’ Deficit [Line Items]
Issuance of founder shares								136,906
Founder shares forfeited		13,675
Founder shares outstanding percentage								20.00%
Number of units issued								340,000
Private Placement [Member]
Stockholders’ Deficit [Line Items]
Issuance of founder shares								340,000
Number of units issued		31,500	238,500					340,000
Share issued price per shares (in Dollars per share)								$ 10
Gross proceeds (in Dollars)			$ 2,385,000
Over-Allotment Option [Member]
Stockholders’ Deficit [Line Items]
Number of units issued		31,500
Share issued price per shares (in Dollars per share)		$ 10		$ 10
Gross proceeds (in Dollars)		$ 315,000		$ 315,000

Fair Value Measurements (Details) - Schedule of Assets that are Measured at Fair Value on a Recurring Basis - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Recurring [Member] \| Level 1 [Member]
Schedule of Assets that are Measured at Fair Value on a Recurring Basis [Line Items]
Cash and marketable securities held in Trust Account	$ 1,109,108	$ 26,036,953

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	Oct. 29, 2024	Oct. 03, 2024
Subsequent Events [Line Items]
Notes payable to related party		$ 670,811
Monthly lease payment	$ 1,200
Promissory Note [Member]
Subsequent Events [Line Items]
Payment to promissory notes		$ 80,000

Grafico Azioni Hudson Acquisition I (NASDAQ:HUDAU)
Storico
Da Ott 2024 a Nov 2024

Clicca qui per i Grafici di Hudson Acquisition I

Grafico Azioni Hudson Acquisition I (NASDAQ:HUDAU)
Storico
Da Nov 2023 a Nov 2024

HUDAU Hudson Acquisition I Corporation

Notizie Hudson Acquisition I Corporation - HUDAU

La tua Cronologia

Più Attivi

Toplist

HUDAU Hudson Acquisition I Corporation

Notizie Hudson Acquisition I Corporation - HUDAU

La tua Cronologia